ESAB CORP, 10-K filed on 2/20/2026
Annual Report
v3.25.4
COVER PAGE - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Feb. 12, 2026
Jul. 03, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-41297    
Entity Registrant Name ESAB CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-0923837    
Entity Address, Address Line One 909 Rose Avenue    
Entity Address, Address Line Two 8th Floor    
Entity Address, City or Town North Bethesda    
Entity Address, State or Province MD    
Entity Address, Postal Zip Code 20852    
City Area Code 301    
Local Phone Number 323-9099    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol ESAB    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 7,614
Entity Common Stock Shares Outstanding   60,728,709  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE

Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2026 annual meeting of stockholders (the “2026 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2026 Proxy Statement specifically incorporated herein by reference, the 2026 Proxy Statement is not deemed to be filed as part of this Form 10-K.
   
Entity Central Index Key 0001877322    
Amendment Flag false    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2025    
v3.25.4
AUDIT INFORMATION
12 Months Ended
Dec. 31, 2025
Auditor Information [Abstract]  
Auditor Name Ernst & Young LLP
Auditor Location Tysons, Virginia
Auditor Firm ID 42
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 2,842,555 $ 2,740,803 $ 2,774,766
Cost of sales 1,794,213 1,703,348 1,759,015
Gross profit 1,048,342 1,037,455 1,015,751
Selling, general and administrative expense 608,416 579,778 587,475
Restructuring and other related charges 27,756 10,227 24,110
Operating income 412,170 447,450 404,166
Pension settlement loss 0 12,155 0
Interest expense and other, net 83,910 64,890 85,074
Income from continuing operations before income taxes 328,260 370,405 319,092
Income tax expense 69,157 77,348 95,727
Net income from continuing operations 259,103 293,057 223,365
Loss from discontinued operations, net of taxes (25,871) (22,309) (12,341)
Net income 233,232 270,748 211,024
Income attributable to noncontrolling interest, net of taxes (6,466) (5,906) (5,739)
Net income attributable to ESAB Corporation     $ 205,285
Net income attributable to ESAB Corporation $ 226,766 $ 264,842  
Earnings (loss) per share - basic      
Income from continuing operations (in dollars per share) $ 4.14 $ 4.73 $ 3.59
Loss on discontinued operations (in dollars per share) (0.43) (0.37) (0.20)
Net income per share (in dollars per share) 3.71 4.36 3.39
Earnings (loss) per share - diluted      
Income from continuing operations (in dollars per share) 4.10 4.68 3.56
Loss on discontinued operations (in dollars per share) (0.43) (0.37) (0.20)
Net income per share - diluted (in dollars per share) $ 3.67 $ 4.31 $ 3.36
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 233,232 $ 270,748 $ 211,024
Other comprehensive income (loss):      
Foreign currency translation, net of tax (benefit) expense of $(12,865), $6,141 and $4,545 190,923 (108,472) 47,258
Unrealized loss on derivatives designated and qualifying as cash flow hedges, net of tax benefit of $(497), $(1,611) and $(1,087) (1,816) (5,554) (3,732)
Defined benefit pension and other post-retirement plan activity, net of tax (benefit) expense of $(388), $2,458 and $2,639 (771) 8,918 7,338
Other comprehensive income (loss) 188,336 (105,108) 50,864
Comprehensive income 421,568 165,640 261,888
Comprehensive income attributable to noncontrolling interest 4,944 4,394 5,887
Comprehensive income attributable to ESAB Corporation $ 416,624 $ 161,246 $ 256,001
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Foreign currency translation, tax expense (benefit) $ (12,865) $ 6,141 $ 4,545
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) (497) (1,611) (1,087)
Defined benefit pension and other post-retirement plan activity, net of tax expense (benefit) $ (388) $ (2,458) $ (2,639)
v3.25.4
CONSOLIDATED AND COMBINED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents $ 185,863 $ 249,358
Trade receivables, less allowance for credit losses of $21,765 and $23,850 451,298 370,321
Inventories, net 481,765 403,711
Prepaid expenses 66,103 55,665
Other current assets 76,876 69,327
Total current assets 1,261,905 1,148,382
Property, plant and equipment, net 381,876 298,347
Goodwill 1,949,702 1,651,993
Intangible assets, net 673,006 487,993
Lease asset - right of use 113,310 89,859
Other assets 386,295 357,401
Total assets 4,766,094 4,033,975
CURRENT LIABILITIES:    
Current portion of long-term debt 2,412 15,000
Accounts payable 360,391 318,493
Accrued liabilities 301,986 298,558
Total current liabilities 664,789 632,051
Long-term debt 1,232,540 1,060,739
Other liabilities 657,236 532,936
Total liabilities 2,554,565 2,225,726
Equity:    
Common stock - $0.001 par value - 600,000,000 shares authorized; 60,721,079 and 60,517,574 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 61 61
Additional paid-in capital 1,904,889 1,901,337
Retained earnings 800,806 597,180
Accumulated other comprehensive loss (539,716) (729,574)
Total ESAB Corporation equity 2,166,040 1,769,004
Noncontrolling interest 45,489 39,245
Total equity 2,211,529 1,808,249
Total liabilities and equity $ 4,766,094 $ 4,033,975
v3.25.4
CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 21,765 $ 23,850
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 600,000,000 600,000,000
Common stock, shares issued (in shares) 60,721,079 60,517,574
Common stock, shares outstanding (in shares) 60,721,079 60,517,574
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022   60,094,725,000        
Beginning balance at Dec. 31, 2022 $ 1,388,458 $ 60 $ 1,865,904 $ 159,231 $ (674,988) $ 38,251
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 211,024     205,285   5,739
Dividends declared (13,959)     (13,959)    
Distributions and purchases relating to noncontrolling owners (3,880)         (3,880)
Other comprehensive income (loss), net of tax 50,864       50,716 148
Common stock-based award activity (in shares)   200,909,000        
Common stock-based award activity 15,150   15,150      
Ending balance (in shares) at Dec. 31, 2023   60,295,634,000        
Ending balance at Dec. 31, 2023 1,647,657 $ 60 1,881,054 350,557 (624,272) 40,258
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 270,748     264,842   5,906
Dividends declared (18,219)     (18,219)    
Distributions and purchases relating to noncontrolling owners (4,253)   2,860   (1,706) (5,407)
Other comprehensive income (loss), net of tax (105,108)       (103,596) (1,512)
Common stock-based award activity (in shares)   221,940,000        
Common stock-based award activity $ 17,424 $ 1 17,423      
Ending balance (in shares) at Dec. 31, 2024 60,517,574 60,517,574,000        
Ending balance at Dec. 31, 2024 $ 1,808,249 $ 61 1,901,337 597,180 (729,574) 39,245
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 233,232     226,766   6,466
Dividends declared (23,140)     (23,140)    
Distributions and purchases relating to noncontrolling owners 1,300         1,300
Other comprehensive income (loss), net of tax 188,336       189,858 (1,522)
Common stock-based award activity (in shares)   203,505,000        
Common stock-based award activity $ 3,552 $ 0 3,552      
Ending balance (in shares) at Dec. 31, 2025 60,721,079 60,721,079,000        
Ending balance at Dec. 31, 2025 $ 2,211,529 $ 61 $ 1,904,889 $ 800,806 $ (539,716) $ 45,489
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Other comprehensive income (loss), tax $ 13,750 $ 6,988 $ 6,097
Dividends on common stock (in dollars per share) $ 0.38 $ 0.30 $ 0.23
v3.25.4
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 233,232 $ 270,748 $ 211,024
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and other impairment charges 84,105 66,790 75,034
Net gain on sale of property, plant and equipment (5,645) (986) (1,570)
Stock-based compensation expense 16,937 19,780 16,122
Deferred income tax benefit (35,664) (2,601) (25,408)
Non-cash interest expense 2,864 2,886 1,195
Pension settlement loss 0 12,155 0
Changes in operating assets and liabilities:      
Trade receivables, net (40,014) (4,848) (6,006)
Inventories, net (5,570) (22,495) 17,958
Accounts payable 6,687 31,861 (19,819)
Other operating assets and liabilities 3,635 (17,891) 61,964
Net cash provided by operating activities 260,567 355,399 330,494
Cash flows from investing activities:      
Purchases of property, plant and equipment (47,287) (51,779) (48,178)
Proceeds from sale of property, plant and equipment 6,535 3,805 4,600
Acquisitions, net of cash received (438,314) (153,664) (18,665)
Payment for (Proceeds from) Other Investing Activity (816) (4,058) 0
Net cash used in investing activities (479,882) (205,696) (62,243)
Cash flows from financing activities:      
Proceeds from borrowings on Senior Notes 0 700,000 0
Repayments of borrowings on Term Loan (385,000) (602,500) (12,500)
Proceeds from borrowings on Term Loan 350,000 0 0
Proceeds from borrowings on revolving credit facilities and other 410,715 205,000 574,150
Repayments of borrowings on revolving credit facilities and other (217,149) (237,005) (763,173)
Payment of debt issuance costs (5,396) (10,423) 0
Payment of dividends (21,913) (16,992) (13,342)
Distributions to noncontrolling interest holders (4,171) (3,678) (3,880)
Other financing (13,385) (2,733) (972)
Net cash provided by (used in) financing activities 113,701 31,669 (219,717)
Effect of foreign exchange rates on Cash and cash equivalents 42,119 (34,017) (18,555)
(Decrease) increase in Cash and cash equivalents (63,495) 147,355 29,979
Cash and cash equivalents, beginning of period 249,358 102,003 72,024
Cash and cash equivalents, end of period 185,863 249,358 102,003
Supplemental disclosures:      
Interest payments, net 66,569 62,280 79,148
Income tax payments, net $ 92,690 $ 94,525 $ 132,902
v3.25.4
Organization and Basis of Presentation
12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Basis of Presentation Organization and Basis of Presentation
Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s rich history of innovative products, workflow solutions and its business management system, ESAB Business Excellence (“EBXai”), enables the Company’s purpose of Shaping the world we imagineTM. The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining, automated welding and gas control. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, the Middle East, India, Africa and Asia Pacific.

The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th complete week after the end of the prior quarter.

Basis of Presentation

The accompanying Consolidated Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with generally accepted accounting principles in the United States (“GAAP”). The Consolidated Financial Statements reflect, in the opinion of management, all adjustments necessary to present fairly the Company’s results of operations, financial position and cash flows as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.

The Company’s Consolidated Financial Statements include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed to determine whether or not there is a controlling financial interest. The Consolidated Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as noncontrolling interest.

Russia and Ukraine Conflict

The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2025, Russia represented approximately 5% of the Company’s Net sales, and approximately $9 million of its Net income. Russia has approximately 5% of the Company’s total net assets as of December 31, 2025, including approximately $50 million of Cash and cash equivalents that may be subject to delays in withdrawing from Russia, based upon the current environment at that time. In case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $110 million as of December 31, 2025, which would be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations and cash flows.
v3.25.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Equity Method Investments

Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value.
Revenue Recognition

The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services.

The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information.

The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred.

Taxes Collected from Customers and Remitted to Governmental Authorities
 
The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority.

Research and Development Expense
 
Research and development costs of $44.0 million, $39.2 million and $38.8 million for the years ended December 31, 2025, 2024 and 2023, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects.

Cash and Cash Equivalents
 
Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.

Trade Receivables
 
Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically.
Inventories

Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost of inventories is determined by costing methods that approximate a first-in, first-out (“FIFO”) method.

During the fourth quarter of 2024, the Company changed its inventory costing methodology from the last-in, first-out (“LIFO”) method to the FIFO method for a portion of its inventory. As of the year ended December 31, 2024, all inventory is valued under FIFO. The Company performed this change because it believes FIFO is preferable given it provides a more consistent method for valuing inventory across the Company, better matches costs with revenues, improves comparability with peers and better reflects the current value of inventory at the balance sheet date. The LIFO expense for the year ended December 31, 2023 was $2.1 million, which is not considered material to the Company’s financial statements. The Company recorded the pre-tax cumulative benefit related to this change in accounting principle of $4.3 million as a reduction of Cost of sales for the year ended December 31, 2024. Since these amounts are immaterial to all periods presented, the impact of this change was not retrospectively reflected in prior years.

Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $39.2 million and $41.2 million as of December 31, 2025 and 2024, respectively.

Property, Plant and Equipment
 
Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions and depreciated by the straight-line method over the estimated remaining useful lives of the related assets. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.

Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company.

 The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).

In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value, not to exceed the amount of goodwill attributable to that reporting unit.

When a quantitative impairment test is performed, the Company measures fair value of reporting units based on a combination of the income approach and market approach. Under the income approach, the Company uses a discounted cash flow model that calculates the fair value as the present value of the cash flows of the reporting units. Under the market approach, the fair value of the business based on comparison against certain market information. Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, value of net operating losses, future economic and market conditions and determination of appropriate market comparables. Management bases fair value estimates on assumptions it believes to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from these estimates and the estimate is inherently sensitive to any material changes to the inputs noted above; these changes could potentially impact the fair value of reporting units.
For the year ended December 31, 2025, a quantitative goodwill impairment assessment was performed and for the years ended December 31, 2024 and 2023, a qualitative goodwill impairment assessment was performed for the three reporting units, all of which indicated no impairment existed and therefore, no impairment charges were recorded for the respective periods. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2025 annual impairment test.

In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. Any material deviation in actual results could affect the calculated fair value of the intangible asset. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade names for the years ended December 31, 2025, 2024 and 2023, all of which indicated no impairment existed.

Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
 
Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from five to thirty years.

The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2025, 2024 and 2023.

Derivatives

The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.

All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.

The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.

The Company had certain interest rate swap agreements that were designated and qualified as cash flow hedges. The final swap matured on April 3, 2025. Therefore, the Company does not have any interest rate swaps outstanding as of the year ended December 31, 2025. The effective portion of the fair value of unrealized gain or loss on cash flow hedges was reported as a component of Accumulated other comprehensive loss ("AOCL") with offsetting amounts recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value was reclassified into earnings in the same period or periods during which the hedged
transaction affected earnings. If a derivative were deemed to be ineffective, the change in fair value of the derivative would be recognized directly in earnings.

The Company has certain cross-currency swap agreements that are designated and qualify as a net investment hedge. The changes in the fair value of these instruments are recorded in AOCL in equity partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract.

The Company has certain foreign currency contracts that are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense and other, net, in the Company’s Consolidated Statement of Operations.

Warranty Costs
 
Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims.
 
Income Taxes
 
The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”), which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred.

Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.

The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements.

The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated Statements of Operations.

Interest Expense and Other, Net

Interest expense and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest expense of derivatives designated in hedging relationships. In addition, it is comprised of:
•other non-operating expense (income) items, including certain pension-related activities,
•foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships and
•Argentina highly inflationary accounting transaction exchange loss on cash and cash equivalents remeasured into the Brazilian real - the direct parent’s currency.
See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information.

Foreign Currency Exchange Gains and Losses
 
The Company’s Consolidated Financial Statements are presented in U.S. Dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation in Equity are net of income taxes to the extent the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense and other, net in the Consolidated Statements of Operations for that period.

The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated Statements of Operations.
Year Ended December 31,
202520242023
(In thousands)(1)
Selling, general and administrative expense$(425)$7,136 $11,389 
Interest expense and other, net2,777 (158)1,719 
Foreign currency transaction loss, net(2)
$2,352 $6,978 $13,108 
(1) This table excludes the foreign currency exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations, as described in the “Argentina Highly Inflationary Accounting” paragraph below.
(2) During 2023, the weakening of the Ruble and certain South American currencies drove the increase in the loss on transactions denominated in foreign currencies.

Argentina Highly Inflationary Accounting

Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the Company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated Statements of Operations. In December 2023, the Argentine peso significantly devalued due to changes in the foreign currency exchange policy introduced by the Argentine government.

For the year ended December 31, 2025, the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $5.2 million, Selling, general and administrative expense of $4.6 million and Interest expense and other, net loss of $1.0 million.

For the year ended December 31, 2024, the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $8.9 million, Selling, general and administrative benefit of $0.6 million and Interest expense and other, net loss of $0.3 million.

For the year ended December 31, 2023, the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $11.5 million, Selling, general and administrative expense of $6.7 million and Interest expense and other, net loss of $26.2 million.

Use of Estimates
 
The Company makes certain estimates and assumptions in preparing its Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.
v3.25.4
Recently Issued Accounting Pronouncements
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements Recently Issued Accounting Pronouncements
The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated Financial Statements as well as material updates to previous assessments.

Accounting Guidance Implemented in 2025

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”), which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company has adopted this guidance for the year ended December 31, 2025, refer to Note 8. “Income Taxes” for further information on the impact on the Company’s disclosures.

Recently Issued Accounting Guidance Not Yet Adopted

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which expands disclosure requirements for more detailed information about the types of expenses in commonly presented expense captions. The ASU is effective for fiscal years beginning after December 15, 2026. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.
v3.25.4
Discontinued Operations
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses that it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity included in its Consolidated Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities. Discontinued operations consist primarily of Selling, general and administrative expense, with an associated tax impact that is considered immaterial. See Note 19, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations was $15.0 million, $15.0 million and $15.2 million for the years ended December 31, 2025, 2024 and 2023, respectively.
v3.25.4
Acquisitions
12 Months Ended
Dec. 31, 2025
Business Combination [Abstract]  
Acquisitions Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with its existing portfolio or expand its portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for using the acquisition method and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses exceeded the fair value of acquired identifiable net assets. This excess is attributable to a variety of factors, including, but not limited to, the anticipated future earnings and cash flow potential of the acquired businesses; prevailing market multiples applied to earnings and cash flows in comparable transactions; the competitive nature of the acquisition processes; the strategic benefits of accelerating market entry or enhancing existing product offerings without incurring the time, cost and risk associated with internal development; and the complementary fit and expected synergies these businesses contribute to the Company’s existing operations.

Under the acquisition method of accounting, the Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities from information obtained during due diligence and through other sources. As the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, the Company is able to refine the estimates of fair value and more accurately allocate the purchase price. The fair values of acquired intangibles are determined based on estimates and assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (“EBITDA”), revenue, revenue growth rates, royalty rates and customer attrition rates. These assumptions are forward-looking and could be affected by future economic and market conditions. The Company engages third-party valuation specialists who provide guidance on the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions. The Company makes appropriate adjustments to purchase price allocations prior to completion of the applicable measurement period, as required. Only facts and circumstances that existed as of the acquisition date are considered for subsequent adjustment.
The following describes our acquisition activity for the three years ended December 31, 2025, for which the Company acquired 100% of the equity and voting interest of each acquired entity. None of the goodwill is expected to be deductible for tax purposes.

2025 Acquisitions

Acquisition DateCompanyDescriptionSegment
April 30, 2025Bavaria Schweisstechnik (“Bavaria”)A European provider of submerged-arc welding applicationsEMEA & APAC
June 4, 2025DeltaP s.r.l. (“DeltaP”)A European provider of medical central gas systems and aftermarket servicesEMEA & APAC
July 9, 2025
Aktiv Technologies Private Limited (“Aktiv”)
An industrial gas equipment manufacturer based in India
EMEA & APAC
August 22, 2025
EWM GmbH (“EWM”)
A Global leader in heavy industrial welding equipment and advanced automation
EMEA & APAC

The following table summarizes the preliminary allocation of the purchase price to the assets acquired and liabilities assumed for the year ended December 31, 2025. These amounts, including inventory, property, plant and equipment, intangible assets and deferred taxes are determined based upon certain valuations and studies that have yet to be finalized. Accordingly, the assets acquired and liabilities assumed, as detailed below, are subject to adjustment once the detailed analyses are completed.
EWMAll OthersTotal
(In thousands)
Cash and cash equivalents$10,360 $6,803 $17,163 
Inventories, net40,081 7,662 47,743 
Property, plant and equipment, net51,481 6,284 57,765 
Goodwill(1)
153,567 63,562 217,129 
Intangible assets129,746 46,656 176,402 
Deferred tax liability(38,224)(12,443)(50,667)
Other, net(2)
(12,271)(890)(13,161)
Purchase price consideration$334,740 $117,634 $452,374 
(1) Goodwill for “All Others” includes approximately $39 million for Bavaria and $16 million for Aktiv.
(2) Includes current and non-current amounts and non-controlling interest.

The following table summarizes the values of the significant identifiable intangible assets acquired, excluding Goodwill, for the year ended December 31, 2025:
EWMAll Others
Intangible AssetAmortization PeriodIntangible AssetWeighted-Average Amortization Period
(In thousands)(In years)(In thousands)(In years)
Customer relationships(1)
$89,095 20$37,984 17
Trade names20,536 106,484 10
Technology and other20,115 102,188 5
$129,746 $46,656 
(1) Customer relationships for “All Others” includes approximately $23 million for Bavaria with an amortization period of 18 years.

The fair value of the customer relationships was preliminarily estimated based on the multiple excess earnings approach and the fair value of the trade names was preliminarily estimated based on the relief from royalty method. Other preliminary fair value adjustments were made to inventories and property and equipment to reflect the fair value of certain assets upon acquisition. Deferred taxes were preliminarily adjusted to record the book-tax basis difference of acquisition accounting adjustments primarily related to amounts allocated to intangible assets, certain property and equipment, inventories and other liabilities. The fair value of the cash and cash equivalents and other liabilities were estimated to approximate their book values.
For the year ended December 31, 2025, the above acquisitions added approximately $79 million to Net sales and contributed an immaterial amount related to Net income. The Company incurred approximately $11 million of acquisition-related transaction costs for the acquisitions completed in 2025 in the year ended December 31, 2025. These costs were expensed in Selling, general and administrative expense in the Consolidated Statements of Operations.

2024 Acquisitions

On October 31, 2024, the Company completed the acquisition of SUMIG Soluções para Solda e Corte Ltda., a South American light automation and equipment business for approximately $68 million, net of cash received, to open market opportunities and expand its portfolio in the Americas segment. The Company recognized intangible assets and goodwill of approximately $29 million and $39 million, respectively.

On July 2, 2024, the Company completed the acquisition of ESAB Bangladesh Private Limited, a leading welding company in Bangladesh, for approximately $69 million, net of cash received, to extend its position in this fast-growing region in the EMEA & APAC segment. The Company recognized intangible assets and goodwill of approximately $15 million and $46 million, respectively.

On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America, for approximately $18 million, net of cash received, to expand its portfolio in the Americas segment.

2023 Acquisitions

On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for approximately $19 million, net of cash received, to strengthen the Company’s leading global gas control equipment portfolio in the EMEA & APAC segment.
v3.25.4
Revenue
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company provides fabrication technology advanced equipment, consumables, gas control equipment, related robotics and digital solutions. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the product groups:
Year Ended December 31,
202520242023
(In thousands)
Equipment$971,994 $893,313 $854,949 
Consumables1,870,561 1,847,490 1,919,817 
$2,842,555 $2,740,803 $2,774,766 
The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.

Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2025 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2025, 2024 and 2023, total contract liabilities were $19.7 million, $26.4 million and $31.2 million, respectively, and are included in Accrued liabilities on the Consolidated Balance Sheets. During the years ended December 31, 2025 and 2024, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year.
The table below summarizes the activity in the Company’s Allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets.
Year Ended December 31, 2025
Balance at Beginning of PeriodCharged to Expense, netWrite-Offs and DeductionsForeign Currency TranslationBalance at
End of Period
(In thousands)
Allowance for credit losses $23,850 $(173)$(3,307)$1,395 $21,765 
v3.25.4
Earnings per Share from Continuing Operations
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Earnings per Share from Continuing Operations Earnings per Share from Continuing Operations
The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends that are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Year Ended December 31,
202520242023
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation(1)
$252,637 $287,151 $217,626 
Distributed and undistributed earnings allocated to nonvested shares(1,218)(1,370)(1,555)
Income from continuing operations attributable to common stockholders$251,419 $285,781 $216,071 
Weighted-average shares of Common stock outstanding – basic
60,680,448 60,427,743 60,233,623 
Income per share from continuing operations – basic
$4.14 $4.73 $3.59 
Computation of earnings per share from continuing operations – diluted:
Income from continuing operations attributable to common stockholders$251,419 $285,781 $216,071 
Weighted-average shares of Common stock outstanding – basic
60,680,448 60,427,743 60,233,623 
Net effect of potentially dilutive securities(2)
585,846 674,320 422,123 
Weighted-average shares of Common stock outstanding – dilution
61,266,294 61,102,063 60,655,746 
Net income per share from continuing operations – diluted
$4.10 $4.68 $3.56 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $6.5 million, $5.9 million and $5.7 million for the years ended December 31, 2025, 2024 and 2023, respectively.
(2) Potentially dilutive securities include stock options, performance-based restricted stock units and nonperformance-based restricted stock units.
v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. The classification of tax expense between federal, state and foreign has been recast for prior years to make all years comparable after the adoption of ASU 2023-09.
Year Ended December 31,
202520242023
(In thousands)
Income from continuing operations before income taxes:  
Domestic operations$36,517 $50,212 $37,364 
Foreign operations291,743320,193281,728
328,260 370,405 319,092 
Income tax expense:
Current:
Federal7,566 8,983 12,548 
State1,929 2,6353,760
Foreign91,188 65,495104,522
100,68377,113120,830
Deferred:
Federal(4,381)4,043 (11,897)
State(14)(126)(1,341)
Foreign(27,131)(3,682)(11,865)
(31,526)235 (25,103)
$69,157 $77,348 $95,727 
The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows in the table below.
Year Ended December 31,
2025
(Dollars in thousands)
 United States federal statutory tax $68,950 21.0 %
 State and local income tax, net of federal income tax effect(1)
1,510 0.5 %
 Foreign tax effects:
    United Kingdom:
       Valuation allowance (11,965)(3.7)%
       Other 1,147 0.4 %
    Switzerland:
       Statutory tax rate difference between Switzerland and United States (5,913)(1.8)%
       Other (2,286)(0.7)%
    Peru 5,248 1.6 %
    Other foreign jurisdictions 19,651 6.0 %
 Effect of changes in tax laws or rates enacted in the current period — — %
 Effect of cross-border tax laws:
    Global Intangible Low-Taxed Income inclusion 24,828 7.6 %
    Subpart F income inclusion 9,663 2.9 %
    Foreign-Derived Intangible Income deduction (5,563)(1.7)%
    Foreign tax credit (33,516)(10.2)%
    Other (93)— %
 Tax credits (916)(0.3)%
 Changes in valuation allowances (1,555)(0.5)%
 Nontaxable or nondeductible items:
    Nondeductible officer compensation 4,762 1.5 %
    Other (1,250)(0.4)%
 Changes in unrecognized tax benefits (2,897)(0.9)%
 Other adjustments (646)(0.2)%
$69,157 21.1 %
(1) State taxes in California, Illinois, Kentucky, Louisiana, Minnesota, New York and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in this category.
The following table presents the required disclosures prior to our adoption of ASU 2023-09 and reconciles the taxes calculated at the United States federal statutory tax rate to the total income tax expense for the years ended December 31, 2024 and 2023.
Year Ended December 31,
20242023
(In thousands)
Taxes calculated at the United States federal statutory rate$77,785 $67,010 
State taxes1,956 1,630 
Effect of tax rates on international operations1,823 1,548 
Changes in tax reserves(4,206)10,753 
Research and development tax credits(980)(714)
Effect of United States taxation on international operations5,239 1,527 
Permanent differences, net
(4,061)10,077 
Provision to return(8,350)703 
Withholding taxes6,634 11,172 
Valuation Allowance(761)(12,308)
Other2,269 4,329 
Income tax expense$77,348 $95,727 

For the year ended December 31, 2025, the Company’s effective rate of 21.1% differs from the United States federal statutory rate of 21.0% due to the jurisdictional mix of earnings, including foreign withholding tax, partially offset by the release of a valuation allowance. For the year ended December 31, 2024, the Company’s effective tax rate of 20.9% differed from the United States federal statutory rate of 21.0% due to favorable impacts from an agreement with a taxing authority on the treatment of subsidy income in a foreign jurisdiction, favorable changes in tax reserves primarily related to a final ruling in a tax case in a foreign jurisdiction partially offset by withholding taxes. For the year ended December 31, 2023, the Company’s effective tax rate of 30.0% differed from the United States federal statutory rate of 21.0% due to changes in tax reserves, permanent differences relating to foreign subsidiaries and withholding taxes partially offset by the favorable impact from changes in valuation allowances.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets. The table below shows the temporary differences that gave rise to the significant components of deferred tax assets and liabilities.
December 31,
20252024
(In thousands)
Deferred tax assets:
Post-retirement benefit obligation$1,894 $1,229 
Expenses currently not deductible73,063 59,518 
Net operating loss carryforward90,458 86,716 
Tax credit carryforward8,323 5,137 
Depreciation and amortization6,544 4,286 
Inventory12,892 10,795 
Capitalized R&D costs 22,035 20,556 
Leases27,831 21,490 
Net investment hedge10,859 — 
Valuation allowance(54,883)(65,007)
Deferred tax assets, net199,016 144,720 
Deferred tax liabilities:
Depreciation and amortization(183,201)(125,227)
Leases(28,418)(22,084)
Outside basis differences and other(87,959)(87,434)
Total deferred tax liabilities(299,578)(234,745)
Total deferred tax liabilities, net$(100,562)$(90,025)

Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as broken out in the table below.
December 31,
20252024
(In thousands)
Other assets$58,217 $44,816 
Other liabilities(158,779)(134,841)
Deferred tax liability, net$(100,562)$(90,025)

The Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ended December 31, 2025, the valuation allowance decreased from $65.0 million to $54.9 million primarily due to the release of a valuation allowance in a foreign jurisdiction for which the benefit of the deferred tax asset is now considered more likely than not to be realized. In determining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, when applicable, future taxable income.

The Company has United States federal net operating loss carryforwards of $2.2 million as of December 31, 2025 expiring in years 2029 through 2036. The Company’s ability to use these various carryforwards to offset any taxable income generated in future taxable periods may be limited under Section 382 and other federal tax provisions. As of December 31, 2025 the Company also has $357.0 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany and the Netherlands that may be subject to local tax restriction limitations. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses.

During the year ended December 31, 2025, the Company has not made any material changes to its indefinite reinvestment assertion with respect to earnings reinvested in its foreign operations. The majority of our global unremitted foreign earnings have been taxed or would be exempt from United States tax upon repatriation. The Company has made no provision for United States income taxes or additional non-United States taxes on certain undistributed earnings or outside basis differences of non-United States subsidiaries in which the Company remains indefinitely reinvested. A portion of these undistributed earnings may be subject to foreign and United States tax consequences upon remittance. The Company cannot practically estimate the amount of additional taxes that might be payable on those undistributed earnings.
The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated Financial Statements. The Company’s total unrecognized tax benefits were $18.6 million, $17.1 million and $30.9 million as of December 31, 2025, 2024 and 2023, respectively, inclusive of $5.3 million, $4.7 million and $12.1 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense, which was an expense of $0.2 million, a benefit of $6.2 million and an expense of $7.9 million for the years ended December 31, 2025, 2024 and 2023, respectively.

The table below includes a reconciliation of the beginning and ending amount of gross unrecognized tax benefits (inclusive of associated interest and penalties).
(In thousands)
Balance, January 1, 2023
$20,203 
Addition for tax positions taken in prior periods13,514 
Reductions related to settlements with taxing authorities(4,160)
Other, including the impact of foreign currency translation1,314 
Balance, December 31, 2023
30,871 
Addition for tax positions taken in prior periods6,436 
Reductions for tax positions taken in prior periods(7,825)
Reductions related to settlements with taxing authorities(9,255)
Reductions resulting from a lapse of applicable statute of limitations(51)
Other, including the impact of foreign currency translation(3,092)
Balance, December 31, 2024
17,084 
Addition for tax positions taken in prior periods7,300 
Reductions for tax positions taken in prior periods(2,201)
Reductions related to settlements with taxing authorities(3,624)
Reductions resulting from a lapse of applicable statute of limitations(1,484)
Other, including the impact of foreign currency translation1,513 
Balance, December 31, 2025
$18,588 
 
The Company files numerous group and separate tax returns in Unites States federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various United States and non-United States taxing authorities. The Company is subject to audit by the United States, various states and foreign jurisdictions.

The Company reviews its global tax provisions on a quarterly basis. The Company accrues or adjusts contingent tax liabilities based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations.
The table below includes a breakout of income taxes paid for the year ended December 31, 2025.
Year Ended December 31,
2025
(In thousands)
Federal$872 
State1,439 
Foreign90,379 
$92,690 
Income taxes paid (net of refunds) exceeded 5 percent of total income taxes paid (net of refunds) in the following jurisdictions:
Foreign:
India$11,833 
Brazil11,537 
Switzerland8,724 
China8,572 
United Kingdom6,765 
Peru6,003 
Czech Republic5,798 
Mexico5,039 
v3.25.4
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
 
The following table summarizes Goodwill activity by segment for the years ended December 31, 2025 and 2024.
 Americas
EMEA & APAC
Total
 (In thousands)
Balance, January 1, 2024
$589,875 $998,456 $1,588,331 
Goodwill attributable to acquisition(1)
44,505 46,691 91,196 
Impact of foreign currency translation(4,675)(22,859)(27,534)
Balance, December 31, 2024
629,705 1,022,288 1,651,993 
Goodwill attributable to acquisitions(1)
2,500 217,128 219,628 
Impact of foreign currency translation14,812 63,269 78,081 
Balance, December 31, 2025
$647,017 $1,302,685 $1,949,702 
(1) Includes purchase accounting adjustments associated with acquisitions discussed in Note 5, “Acquisitions.”

The following table summarizes the Company’s Intangible assets, excluding Goodwill.
 December 31,
 20252024
 Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets:
Trade names$197,120 $— $173,912 $— 
Definite-Lived Intangible Assets:
Customer relationships661,002 (288,727)506,226 (248,920)
Technology101,214 (64,631)71,912 (55,539)
Trade names58,553 (16,428)28,878 (11,832)
Software91,802 (73,731)78,122 (62,391)
Other intangible assets31,219 (24,387)30,424 (22,799)
 $1,140,910 $(467,904)$889,474 $(401,481)
 
Amortization expense related to intangible assets of $43.3 million, $36.0 million and $39.7 million for the years ended December 31, 2025, 2024 and 2023, respectively, is included in Selling, general and administrative expense in the Consolidated Statements of Operations.
 
The Company’s expected annual amortization expense for intangible assets for the next five years is as follows.
 December 31, 2025
 (In thousands)
2026$43,037 
202738,989 
202836,106 
202934,794 
203032,888 
v3.25.4
Property, Plant and Equipment, Net
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net Property, Plant and Equipment, Net
  December 31,
 Depreciable Life20252024
 (In years)(In thousands)
Landn/a$23,481 $14,484 
Buildings and improvements
5-40
233,850 176,077 
Machinery and equipment
3-15
486,676 409,045 
  744,007 599,606 
Accumulated depreciation (362,131)(301,259)
 $381,876 $298,347 
Depreciation expense for the years ended December 31, 2025, 2024 and 2023 was $40.7 million, $30.6 million and $30.0 million, respectively.
v3.25.4
Inventories, Net
12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Inventories, Net Inventories, Net
December 31,
20252024
(In thousands)
Raw materials$173,458 $151,248 
Work in process40,033 41,698 
Finished goods307,517 251,994 
521,008 444,940 
Less: allowance for excess, slow-moving and obsolete inventory(39,243)(41,229)
$481,765 $403,711 
v3.25.4
Leases
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases
The Company leases certain office spaces, warehouses, production facilities, vehicles and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. During the year ended December 31, 2025, the Company recognized a non-cash transaction for a new material operating lease in the EMEA & APAC segment totaling approximately $29 million in Right-of-use lease asset and related lease liability. Operating lease expense was $28.7 million, $24.9 million and $25.4 million for the years ended December 31, 2025, 2024 and 2023, respectively.
December 31, 2025
(In thousands)
Future lease payments by year:
2026$28,379 
202726,093 
202819,582 
202914,418 
203012,754 
Thereafter50,245 
151,471 
Less: present value discount(41,249)
Present value of lease liabilities$110,222 
Weighted-average remaining lease term (in years):
Operating leases7.1
Weighted-average discount rate:
Operating leases8.5 %
v3.25.4
Accrued and Other Liabilities
12 Months Ended
Dec. 31, 2025
Accrued Liabilities [Abstract]  
Accrued and Other Liabilities Accrued Liabilities and Other Liabilities
The table below includes a summarized breakout of Accrued liabilities and Other liabilities in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$53,728 $182,898 $46,395 $151,642 
Compensation and related benefits68,53552,70680,45148,350
Asbestos liability 42,242269,82940,779253,287
Contract liability19,663—26,390—
Lease liability22,08188,14121,45966,042
Warranty liability 12,573—12,794—
Third-party commissions19,371—17,346—
Restructuring liability17,2973194,732374
Accrued interest8,570—8,077—
Other37,92663,34340,13513,241
$301,986 $657,236 $298,558 $532,936 

The table below summarizes the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets.
Year Ended December 31,
20252024
(In thousands)
Warranty liability, beginning of period$12,794 $12,606 
Accrued warranty expense8,926 10,570 
Changes in estimates related to pre-existing warranties762 1,624 
Cost of warranty service work performed(12,146)(11,426)
Foreign exchange translation effect and other2,237 (580)
Warranty liability, end of period$12,573 $12,794 
The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. The table below summarizes the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets.
Year Ended December 31, 2025
Balance at Beginning of PeriodChargesPaymentsForeign Currency Translation and OtherBalance at End of Period
(In thousands)
Termination benefits(1)
$3,845 $19,174 $(8,678)$709 $15,050 
Facility closure costs and other(2)
1,261 8,582 (6,245)(1,032)2,566 
$5,106 $27,756 $(14,923)$(323)$17,616 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment and other costs in connection with the closure and optimization of facilities and product lines.

Year Ended December 31, 2024
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Termination benefits(1)
$4,595 $4,538 $(5,288)$— $3,845 
Facility closure costs(2)
1,104 5,689 (5,112)(420)1,261 
$5,699 $10,227 $(10,400)$(420)$5,106 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expenses and other costs in connection with the closure and optimization of facilities and product lines.
v3.25.4
Benefit Plans
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans
The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The other post-retirement benefit plans are immaterial. The Company uses December 31st as the measurement date for all of its employee benefit plans.
The following table summarizes the total changes in the Company’s total and foreign pension benefits and plan assets and includes a statement of the plans’ funded status.
 All Pension BenefitsForeign Pension Benefits
 Year Ended December 31,Year Ended December 31,
 2025202420252024
 (In thousands)
Change in benefit obligation:    
Projected benefit obligation, beginning of year$189,874 $242,743 $63,898 $99,215 
Service cost1,466 1,429 1,466 1,429 
Interest cost8,475 8,828 2,513 2,576 
Plan amendments1,671 (9)1,671 (9)
Actuarial loss (gain)1,109 (5,945)(1,721)1,178 
Foreign exchange effect8,112 (5,386)8,112 (5,386)
Benefits paid(17,533)(21,242)(4,760)(4,561)
Settlements(1,314)(31,583)(1,314)(31,583)
Other4,759 1,039 4,759 1,039 
Projected benefit obligation, end of year196,619 189,874 74,624 63,898 
Accumulated benefit obligation, end of year192,972 186,689 70,977 60,713 
Change in plan assets:
Fair value of plan assets, beginning of year161,906 211,472 21,894 65,278 
Actual return on plan assets8,657 12,389 1,068 2,024 
Employer contributions4,874 4,309 4,750 4,175 
Foreign exchange effect1,930 (2,028)1,930 (2,028)
Benefits paid(17,533)(21,242)(4,760)(4,561)
Settlements(1,314)(43,283)(1,314)(43,283)
Other3,809 289 3,809 289 
Fair value of plan assets, end of year162,329 161,906 27,377 21,894 
Funded status, end of year(34,290)(27,968)(47,247)(42,004)
Amounts recognized on the Consolidated Balance Sheets as of December 31:
Non-current assets16,194 17,228 2,164 2,072 
Current liabilities(4,039)(3,113)(3,914)(2,979)
Non-current liabilities(46,445)(42,083)(45,497)(41,097)
$(34,290)$(27,968)$(47,247)$(42,004)

For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $56.3 million and $8.8 million, respectively, as of December 31, 2025 and $49.3 million and $6.3 million, respectively, as of December 31, 2024. For pension plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $62.3 million and $11.8 million, respectively, as of December 31, 2025 and $52.4 million and $7.2 million, respectively, as of December 31, 2024.

Expected contributions to the Company’s pension benefit plans for the year ending December 31, 2026 are $5.2 million. The table below includes the benefit payments that are expected to be paid during each respective fiscal year.
 Pension Benefits
 All PlansForeign Plans
 (In thousands)
2026$20,672 $7,685 
202719,078 6,525 
202818,208 6,063 
202917,878 6,229 
203017,812 6,666 
2031 – 203577,553 29,705 
The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction, and in various locations (including the United States) has been adjusted to reduce investment risk during the year ended December 31, 2025.

The table below shows the actual allocation percentages for the Company’s pension plan assets.
 Actual Asset Allocation
December 31,
 20252024
United States Plans:
Equity securities:
United States— %37 %
International— %13 %
Fixed income90 %50 %
Cash and cash equivalents10 %— %
Foreign Plans:
Equity securities— %4 %
Fixed income14 %15 %
Cash and cash equivalents1 %1 %
Insurance contracts51 %44 %
Investment funds(1)
34 %36 %
 
(1) Represents various fixed income and equity securities.
The table below summarizes the Company’s pension plan assets for each fair value hierarchy level for the periods presented (see Note 17, “Fair Value Measurements” for further description of the levels within the fair value hierarchy).
 December 31, 2025December 31, 2024
 
Measured at Net Asset Value (1)
Level
One
Level
Two
Level
Three
 
Total
Measured at Net Asset Value(1)
Level
One
Level
Two
Level
Three
 
Total
 (In thousands)
United States Plans:
Cash and cash equivalents $— $13,097 $— $— $13,097 $— $379 $— $— $379 
Equity securities:
United States large cap— — — — — 28,803 — — — 28,803 
United States small/mid cap— — — — — 9,456 13,481 — — 22,937 
International— — — — — 17,566 — — — 17,566 
Fixed income mutual funds:
United States government and corporate121,856 — — — 121,856 69,152 — — — 69,152 
Other — — — — — — 1,175 — — 1,175 
Foreign Plans:
Cash and cash equivalents(2)
— 237 — — 237 — 238 — — 238 
Equity securities— 95 — — 95 — 904 — — 904 
Non-United States government and corporate bonds— 3,679 — — 3,679 — 3,198 — — 3,198 
Insurance contracts— — 14,040 — 14,040 — — 9,608 — 9,608 
Investment funds— — 9,298 — 9,298 — — 7,919 — 7,919 
Other— — 27 — 27 — — 27 — 27 
 $121,856 $17,108 $23,365 $— $162,329 $124,977 $19,375 $17,554 $— $161,906 
(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term.
(2)The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
The following table sets forth the components of net periodic benefit cost and Other comprehensive income (loss) of the Company’s total and foreign defined benefit pension plans.
 All Pension BenefitsForeign Pension Benefits
 Year Ended December 31,Year Ended December 31,
 202520242023202520242023
 (In thousands)
Components of Net Periodic Benefit Cost:    
Service cost$1,466 $1,429 $1,439 $1,466 $1,429 $1,439 
Interest cost8,475 8,828 11,170 2,513 2,576 4,148 
Amortization1,500 1,634 1,206 155 130 40 
Settlement loss(1)
— 12,155 — — 12,155 — 
Other122 (179)— 122 (179)(331)
Expected return on plan assets(7,917)(9,410)(11,391)(881)(1,038)(2,475)
Net periodic benefit cost3,646 14,457 2,424 3,375 15,073 2,821 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Current year net actuarial loss (gain)1,501 (9,598)(7,021)(777)(483)1,984 
Current year prior service cost (income)1,620 (9)175 1,620 (9)175 
Less amounts included in net periodic benefit cost:
Amortization of net loss(1,506)(1,676)(1,575)(161)(172)(78)
Settlement / divestiture / other loss(114)(455)(1,079)(114)(454)(1,079)
Amortization of prior service cost (income)6 42 38 6 42 38 
Total recognized in Other comprehensive income (loss)$1,507 $(11,696)$(9,462)$574 $(1,076)$1,040 
 
(1)During the year ended December 31, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan.

Each component of net periodic benefit cost is included in the Company’s Consolidated Statements of Operations for the years ended December 31, 2025, 2024 and 2023. Service cost is included within Selling, general and administrative expense with the non-service costs net of expected return on plan assets and settlement loss included within Interest expense and other, net. Settlement loss is recorded within Pension settlement loss on the Company’s Consolidated Statement of Operations.

The table below shows the components of net unrecognized pension benefit cost included in AOCL in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost.
 December 31,
 20252024
 (In thousands)
Net actuarial loss$49,797 $49,917 
Prior service cost (income)1,505 (122)
$51,302 $49,795 
 
The key economic assumptions used in the measurement of the Company’s pension benefit obligations are included in the table below.
 December 31,
 20252024
Weighted-average discount rate:  
All plans4.7 %4.8 %
Foreign plans4.3 %3.7 %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.5 %3.1 %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
The key economic assumptions used in the computation of net periodic benefit cost are as included in the table below.
 Year Ended December 31,
 202520242023
Weighted-average discount rate:  
All plans4.8 %4.4 %4.6 %
Foreign plans3.7 %3.9 %4.3 %
Weighted-average expected return on plan assets:
All plans4.8 %5.1 %5.0 %
Foreign plans4.1 %4.4 %4.1 %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.1 %3.1 %3.2 %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
 
In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date.

The expected long-term rate of return on plan assets is determined using the calculated value of plan assets, which is based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans.

The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2025, 2024 and 2023 was $7.7 million, $7.5 million and $7.6 million, respectively.
v3.25.4
Debt
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Debt Debt
The table below shows the components of the Company’s debt.
December 31,
20252024
(In thousands)
Term loan$350,000 $385,000 
Senior unsecured notes700,000 700,000 
Revolving credit facility185,000 — 
Other debt8,215 — 
Total debt1,243,215 1,085,000 
Current portion of debt(2,412)(15,000)
Unamortized deferred financing fees(8,263)(9,261)
Long-term debt$1,232,540 $1,060,739 

Senior Notes, Term Loan and Revolving Credit Facility            

On April 4, 2022, the Company entered into a credit agreement that initially consisted of (i) a $750 million revolving credit facility with a maturity date of April 4, 2027, (ii) a senior term loan A-1 facility with an initial aggregate principal amount of $400 million, with a maturity date of April 4, 2027 and (iii) a $600 million 364-day senior term loan A-2 facility with a maturity date of April 3, 2023. The senior term loan A-2 facility was subsequently refinanced in June 2022 extending its maturity date to April 3, 2025 to become senior term loan A-3 facility.

On April 9, 2024, the Company issued $700 million in aggregate principal amount of 6.25% senior notes due 2029 (the “Senior Notes”) governed by an indenture (the “Indenture”). The Senior Notes have a contractual maturity interest rate of 6.25% and maturity date of April 15, 2029. The Company used the net proceeds from the Senior Notes to pay off its senior term loan A-3 facility and pay fees associated with the offering.

On October 16, 2025, the Company entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) that, among other things, provides for (i) a senior term loan A facility (the “Term Loan A Facility”) in an
aggregate principal amount of $350 million, and (ii) a senior revolving credit facility (the “Revolving Facility”) in the amount of $1.05 billion to replace the Company’s existing $400 million senior term loan A-1 facility and $750 million revolving credit facility and pay off the outstanding principal and interest thereunder. Both facilities mature on October 16, 2030, subject to a springing maturity date under certain circumstances. The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility.

As of December 31, 2025, the A&R Credit Agreement and the Indenture consist of the following facilities:
•A $1.05 billion Revolving Facility with a maturity date of October 16, 2030, with $185 million drawn;
•A Term Loan A Facility with an aggregate principal amount of $350 million, with maturity dates through October 16, 2030; and
•Senior Notes with an aggregate principal amount of $700 million with a maturity date of April 15, 2029.

The A&R Credit Agreement and the Indenture contain customary covenants. These covenants limit the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the A&R Credit Agreement requires that the Company maintains certain financial covenants and the Company was in compliance with all of its debt covenants as of December 31, 2025. The A&R Credit Agreement and the Indenture contain various events of default (including failure to comply with the covenants under the A&R Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Loan A Facility, Senior Notes and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the A&R Credit Agreement and the Senior Notes.
Loans made under the Term Loan A Facility will bear interest, at the election of the Company, at either the base rate (as defined in the A&R Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) plus an adjustment (as defined in the A&R Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in Dollars, the term SOFR plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in Euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) and, (iii) in the case of loans denominated in Sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the A&R Credit Agreement), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.

To manage exposures to currency exchange rates and interest rates arising in Long-term debt, the Company has interest rate swap agreements. Refer to Note 16, “Derivatives” for additional information.

As of December 31, 2025, the weighted-average interest rate of borrowings under the A&R Credit Agreement and the Indenture was 5.40%, excluding accretion of deferred financing fees. There was approximately $865 million of borrowing capacity available on the Revolving Facility, subject to the Company meeting financial covenants and other requirements.

Other Indebtedness

In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $50 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company has used from time to time in the past for short-term working capital needs.

The Company is party to letter of credit facilities with an aggregate capacity of $113.3 million. Total letters of credit of $33.7 million were outstanding as of December 31, 2025.

Deferred Financing Fees

The Company had total deferred financing fees of $12.5 million included in its Consolidated Balance Sheets as of December 31, 2025, which will be charged to Interest expense and other, net, over the term of the related debt instruments. The costs associated with the Term Loan A Facility and Senior Notes noted above will be amortized over the contractual term of the related facility. Of the $12.5 million, $4.2 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $8.3 million of deferred financing fees relating to the Term Loan A Facility and Senior Notes are recorded as a contra-liability within Long-term debt.
Other

The Company’s minimum principal payments for the next five years are broken out in the table below.
December 31, 2025
(In thousands)
2026$2,412 
202710,408 
202810,408 
2029719,158 
2030500,829 
Total debt(1)
$1,243,215 
 
(1)Total debt excludes $8.3 million of related unamortized deferred financing fees.
v3.25.4
Derivatives
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives Derivatives
The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.

The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2025. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated Balance Sheets at fair value.

Cash Flow Hedges

On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts was $600 million, maturing in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company.

In March 2024, the Company settled one of the interest rate swaps associated with the Company’s floating-rate debt and received $5.5 million in connection with that settlement. The termination of the interest rate swap was related to the repayment of the Term A-3 Facility in April 2024. Refer to Note 15, “Debt” for further information. As this interest rate swap was designated as a cash flow hedge, $5.5 million was deferred in AOCL and was recognized in earnings over the period the originally forecasted hedged transaction impacts earnings. The remaining $300 million swap was hedged against the remaining floating-rate debt through its maturity on April 3, 2025. Therefore, the Company does not have any interest rate swaps outstanding as of the year ended December 31, 2025.

The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges were classified in cash flows from operating activities in the accompanying Consolidated Statements of Cash Flows.

Net Investment Hedges

On July 22, 2022, the Company entered into two cross-currency swap agreements, set to mature in April 2025, to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. The cross-currency swap agreements included provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and were designated and qualified as a net investment hedge. These contracts had a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million.

Prior to the maturity of these two cross-currency swaps, on June 25, 2024, the Company de-designated these swaps and entered into four new cross-currency swaps for the same notional amounts that mature in October 2026.
On August 22, 2024, the Company entered into two additional cross-currency swap agreements, set to mature in October 2026. These contracts have a Euro aggregate notional amount of approximately €90 million and a U.S. dollar aggregate notional amount of $100 million. These swaps are designated and accounted for as a net investment hedge.

The changes in the spot rate of these instruments are recorded in AOCL in equity partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense and other, net line item in the Consolidated Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCL into earnings during the period of change. Due to the de-designation transaction above on June 25, 2024, the Company will keep the balance in AOCL related to the original derivative for the duration that the investment is held. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2025.

The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated Statements of Cash Flows.

The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets.
December 31, 2025
December 31, 2024
Designated as hedging instrumentsOther LiabilitiesOther AssetsOther LiabilitiesOther Assets
(In thousands)
Cross-currency swap agreements $48,778 $— $1,830 $— 
Interest rate swap agreement— — — 842 
$48,778 $— $1,830 $842 

Derivatives Not Designated as Hedging Instruments

The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2025 and December 31, 2024, the Company had foreign currency contracts related to purchases and sales with notional values of $105.2 million and $178.7 million, respectively.

The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets.
December 31, 2025
December 31, 2024
Not designated as hedging instrumentsAccrued LiabilitiesOther Current AssetsAccrued LiabilitiesOther Current Assets
(In thousands)
Foreign currency contracts$183 $780 $379 $255 

The amounts in the table above as of December 31, 2025 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $0.1 million increase in Other current assets with a corresponding increase in Accrued liabilities.
v3.25.4
Fair Value Measurements
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.
Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is in the table below (see Note 14, “Benefit Plans” for classification of the assets of the Company’s benefit plans within the fair value hierarchy).
December 31, 2025December 31, 2024
Level
One
Level
Two
Level
Three
TotalLevel
One
Level
Two
Level
Three
Total
(In thousands)
Assets:
Cash equivalents$11,965 $— $— $11,965 $8,990 $— $— $8,990 
Foreign currency contracts— 857 — 857 — 657 — 657 
Interest rate swap agreement— — — — — 842 — 842 
Deferred compensation plans— 7,214 — 7,214 — 5,242 — 5,242 
11,965 8,071 — 20,036 8,990 6,741 — 15,731 
Liabilities:
Foreign currency contracts— 260 — 260 — 781 — 781 
Cross-currency swap agreements— 48,778 — 48,778 — 1,830 — 1,830 
Deferred compensation plans— 7,214 — 7,214 — 5,242 — 5,242 
$— $56,252 $— $56,252 $— $7,853 $— $7,853 

The Company’s cash equivalents consist of investments in foreign interest-bearing deposit accounts and foreign money market mutual funds that are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities.

The Company measures the fair value of foreign currency contracts, cross-currency swap agreements and interest rate swap agreement using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2025, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information. There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2025 and 2024.

Concentration of Credit Risk

Financial instruments that are potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems necessary. There are no customers that represent more than 10% of the Company’s Trade receivables, net as of December 31, 2025 and 2024.
v3.25.4
Equity
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Equity Equity
Share Repurchase Program

On August 13, 2024, the Board of Directors authorized and approved a stock repurchase program to repurchase up to five million shares of the Company’s Common stock, par value $0.001 per share, from time-to-time on the open market, in privately negotiated transactions or as may otherwise be determined by the Company’s management in its discretion. No repurchases of the Company’s Common stock have been made through the year ended December 31, 2025 since program inception. The timing and amount of any shares repurchased will be determined by the Company’s management based on its evaluation of market conditions, applicable legal requirements and other factors. There is no term associated with the repurchase authorization.

Accumulated Other Comprehensive Loss

The following table presents the changes in the balances of each component of AOCL including reclassifications out of AOCL for the years ended December 31, 2025, 2024 and 2023. All amounts are net of tax and noncontrolling interest, if any.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at January 1, 2023
$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
Other comprehensive income (loss) before reclassifications:
Net actuarial gain8,969 — — — 8,969 
Foreign currency translation adjustment(3,285)(11,143)(8,879)— (23,307)
Gain on long-term intra-entity foreign currency transactions— 70,428 — — 70,428 
Unrealized gain on cash flow hedges— — — 4,834 4,834 
Other comprehensive income (loss) before reclassifications5,684 59,285 (8,879)4,834 60,924 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
(1,642)— — (8,566)(10,208)
Net current period Other comprehensive income (loss)4,042 59,285 (8,879)(3,732)50,716 
Balance at December 31, 2023
(59,805)(554,622)(17,215)7,370 (624,272)
Other comprehensive income (loss) before reclassifications:
Net actuarial gain9,069 — — — 9,069 
Foreign currency translation adjustment530 (137,599)15,968 — (121,101)
Gain on long-term intra-entity foreign currency transactions— 14,136 — — 14,136 
Unrealized gain on cash flow hedges— — — 4,426 4,426 
Other comprehensive income (loss) before reclassifications9,599 (123,463)15,968 4,426 (93,470)
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
(146)— — (9,980)(10,126)
Purchase related to noncontrolling interest— (1,706)— — (1,706)
Net current period Other comprehensive income (loss)9,453 (125,169)15,968 (5,554)(105,302)
Balance at December 31, 2024
(50,352)(679,791)(1,247)1,816 (729,574)
Other comprehensive (loss) income before reclassifications:
Net actuarial loss(1,811)— — — (1,811)
Foreign currency translation adjustment(899)224,018 (36,467)— 186,652 
Gain on long-term intra-entity foreign currency transactions— 5,448 — — 5,448 
Unrealized gain on cash flow hedges— — — 16 16 
Other comprehensive (loss) income before reclassifications(2,710)229,466 (36,467)16 190,305 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
1,385 — — (1,832)(447)
Net current period Other comprehensive (loss) income(1,325)229,466 (36,467)(1,816)189,858 
Balance at December 31, 2025
$(51,677)$(450,325)$(37,714)$— $(539,716)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details.
(2) The amounts on this line within the Cash Flow Hedges column are a component of Interest expense and other, net. See Note 16, “Derivatives,” for additional details.
Share-Based Payments

The Company adopted the 2022 Omnibus Incentive Plan on April 4, 2022 (as subsequently amended and restated, effective as of May 8, 2025, the “Stock Plan”). The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated Statements of Operations.

Stock Options

 Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. With limited exceptions, the employee must remain in service until the vesting date. For the year ended December 31, 2025, the Stock-based compensation expense for the stock option awards was $3.0 million. As of December 31, 2025, the Company had $2.9 million of unrecognized compensation expense related to stock option awards that will be recognized over a weighted-average period of 1.8 years.

Restricted Stock Units

During the year ended December 31, 2023, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods. These PRSUs are valued at the market value of a share of common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed. During the year ended December 31, 2024 and December 31, 2025, the Company granted certain employees PRSUs, the calculation of the final achievement of which is based on Company-specific performance metrics as well as a modifier for the Company’s total shareholder return ranking among a peer group over a three-year performance period. The awards also have a service requirement that equals the respective performance periods. The related compensation expense for each of the awards is recognized on a straight-line basis over the vesting period. For the year ended December 31, 2025, the Stock-based compensation expense for the PRSUs was $2.7 million.

Under the Stock Plan, the Compensation Committee may also award RSUs to select executives, employees and outside directors, which typically vest over three years after the date of grant. With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards. For the year ended December 31, 2025, the Stock-based compensation expense for the RSUs was $11.2 million.
The activity of the Company’s PRSUs and RSUs is included in the table below.
 PRSUsRSUs
 Number of UnitsWeighted- Average
Grant-Date Fair Value
Number of UnitsWeighted-Average
Grant-Date Fair Value
Balance at December 31, 2024
200,642 $68.44 373,620 $67.02 
Granted100,947 131.81 129,729 123.38 
Vested93,799 49.43 173,517 62.38 
Forfeited and expired20,231 90.83 31,235 87.65 
Balance at December 31, 2025
187,559 $97.48 298,597 $92.20 

The fair value of shares vested during the year ended December 31, 2025 was $15.5 million. As of December 31, 2025, the Company had $24.7 million of unrecognized compensation expense related to PRSU and RSU awards that will be recognized over a weighted-average period of 2.4 years.
v3.25.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Asbestos Contingencies

Certain subsidiaries of the Company are the legal obligor, or owner, for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations of the Company’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers and were not manufactured by any of the Company’s subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the United States Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual number of cases and average settlement payment per asbestos claimant has fluctuated during the past several years. The Company expects such settlement value fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment to plaintiffs.

The Company has classified asbestos-related activity in Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. It is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability at its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate insurance coverage that was acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies and law pertaining to the affected subsidiary’s insurance policies.

The table below summarizes the Asbestos-related claims activity for the years ended December 31, 2025 and 2024, respectively.
Year Ended December 31,
20252024
(Number of claims)
Claims unresolved, beginning of period13,758 13,648 
Claims filed(1)
5,279 5,005 
Claims resolved(2)
(4,201)(4,895)
Claims unresolved, end of period14,836 13,758 
(In dollars)
Average cost of resolved claims(3)
$12,018 $10,574 
(1) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.
(3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.

The Company’s Consolidated Balance Sheets include the amounts related to asbestos-related litigation shown in the table below.
December 31,
20252024
(In thousands)
Long-term asbestos insurance asset(1)
$235,361 $234,951 
Long-term asbestos insurance receivable(1)
16,811 16,961 
Accrued asbestos liability(2)
42,242 40,779 
Long-term asbestos liability(3)
269,829 253,287 
(1) Included in Other assets in the Consolidated Balance Sheets.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.
(3) Included in Other liabilities in the Consolidated Balance Sheets.

Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded that could materially affect the Company’s financial condition, results of operations or cash flow. From time to time, other asbestos allegations related to the Company’s legacy industrial businesses are brought against the Company. Management currently believes no loss is probable or estimable for these other matters.

General Litigation

The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings are expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

Off-Balance Sheet Arrangements

As of December 31, 2025, the Company had $162.4 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2026.
v3.25.4
Segment Information
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, the Middle East, India, Africa and Asia Pacific.

The Company’s management considers its Chief Operating Decision Maker (“CODM”) to be Shyam Kambeyanda, President, Chief Executive Officer and Director. The Company’s management and CODM evaluate the operating results of each reportable segment, including assessment of profit or loss, performance and allocation of resources, based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net, Pension settlement loss, Restructuring and other related charges, acquisition transaction, due
diligence and integration expenses, amortization of intangibles and fair value charges on acquired inventories and depreciation and other amortization. Segment results reflect the allocation of overhead costs, which primarily consist of Selling, general and administrative expense.

The Company’s segment results are included in the table below.
Year Ended December 31,
202520242023
(In thousands)
Net sales(1):
Americas$1,130,338 $1,176,745 $1,214,998 
EMEA & APAC1,712,217 1,564,058 1,559,768 
2,842,555 2,740,803 2,774,766 
Cost of sales:
Americas693,108 711,082 760,134 
EMEA & APAC1,101,105 992,266 998,881 
1,794,213 1,703,348 1,759,015 
Allocated operating expense:
Americas51,057 64,517 64,668 
EMEA & APAC93,724 97,807 103,984 
144,781 162,324 168,652 
Other operating expense:
Americas160,805 161,946 165,454 
EMEA & APAC183,046 184,411 180,543 
343,851 346,357 345,997 
Adjusted EBITDA(2):
Americas225,368 239,200 224,742 
EMEA & APAC334,342 289,574 276,360 
559,710 528,774 501,102 
Depreciation, amortization and other impairment charges:
Americas34,050 30,813 34,589 
EMEA & APAC50,055 35,977 40,445 
84,105 66,790 75,034 
Capital expenditures:
Americas18,791 22,645 21,576 
EMEA & APAC28,496 29,134 26,602 
$47,287 $51,779 $48,178 
(1) For the years ended December 31, 2025, 2024 and 2023, the total Net sales originating from the United States were $579.3 million, $595.6 million and $619.1 million, respectively.
(2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA on a consolidated basis:
Year Ended December 31,
202520242023
(In thousands)
Net income from continuing operations$259,103 $293,057 $223,365 
Income tax expense69,157 77,34895,727
Interest expense and other, net83,910 64,890 85,074 
Pension settlement loss— 12,155 — 
Restructuring and other related charges(1)
27,756 10,227 24,110 
Acquisition - amortization and other related charges(2)
72,063 34,479 36,851 
Depreciation and other amortization47,721 36,618 35,975 
Adjusted EBITDA$559,710 $528,774 $501,102 
(1) Includes severance and other termination benefits, including outplacement services, as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(2) Includes transaction, diligence and integration expenses totaling $31.5 million, $4.2 million and $2.6 million for the years ended December 31, 2025, 2024 and 2023, respectively, and amortization of intangibles and fair value charges on acquired inventories totaling $40.5 million, $30.3 million and $34.2 million for the years ended December 31, 2025, 2024 and 2023, respectively.

The Company’s investments in equity method investees and total assets by segment are included in the table below.
December 31,
20252024
(In thousands)
Investments in equity method investees:
Americas$— $— 
EMEA & APAC29,558 28,885 
29,558 28,885 
Total assets:
Americas1,717,390 1,796,167 
EMEA & APAC3,048,704 2,237,808 
$4,766,094 $4,033,975 

The detail of the Company’s property, plant and equipment, net by geography are included in the table below.
December 31,
20252024
(In thousands)
Property, plant and equipment, net(1):
Czech Republic$75,028 $55,554 
United States72,617 73,036 
Germany48,245 11,191 
India31,437 31,506 
Mexico23,464 20,495 
Other foreign countries131,085 106,565 
$381,876 $298,347 
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.
v3.25.4
Subsequent Events
12 Months Ended
Dec. 31, 2025
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
The dividend of $6.1 million included in Accrued liabilities in the Consolidated Balance Sheets at December 31, 2025 was paid on January 16, 2026, to stockholders of record as of December 31, 2025.

On January 31, 2026, the Company entered into an agreement to acquire Eddyfi Technologies (“Eddyfi”), a global leader in advanced inspection and monitoring technologies headquartered in Quebec, Canada, for approximately $1.45 billion. The acquisition is expected to be funded with a combination of cash on hand, debt and approximately $318 million of fully committed equity. The Company obtained a commitment for a $1.0 billion 364-day senior unsecured bridge term loan credit facility from JPMorgan Chase Bank, N.A., which will be available to fund the cash consideration for the acquisition and related fees and expenses. This acquisition is expected to be completed in mid-2026, subject to the receipt of applicable regulatory approvals and customary closing conditions.
v3.25.4
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Balance at
Beginning
of Period
Charged to Cost and
Expense
(1)
Write-Offs Write-Downs
Deductions and Other
Foreign
Currency
Translation
Balance at
End of
Period
(in thousands)
Year Ended December 31, 2025:
Allowance for credit losses$23,850 $(173)$(3,307)$1,395 $21,765 
Valuation allowance for deferred tax assets65,007 (13,285)2,997 164 54,883 
Year Ended December 31, 2024:
Allowance for credit losses$25,477 $2,248 $(2,423)$(1,452)$23,850 
Valuation allowance for deferred tax assets79,355 (761)(12,478)(1,109)65,007 
Year Ended December 31, 2023:
Allowance for credit losses$23,471 $3,902 $(2,289)$393 $25,477 
Valuation allowance for deferred tax assets88,202 (12,283)— 3,426 79,355 
(1)    Amounts charged to expense are net of recoveries for the respective period.
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Arrangement Duration 112 days
Ms. Michele Campion [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On November 7, 2025, Ms. Michele Campion, Chief Human Resources Officer of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i) 7,196 shares of Company common stock on February 27, 2026, subject to
certain conditions, all of which shares are to be acquired upon exercise of employee stock options and (ii) 2,200 shares of Company common stock on February 27, 2026, subject to certain conditions.
Name Ms. Michele Campion
Title Chief Human Resources Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 7, 2025
Aggregate Available 7,196
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity related risks are integrated into our overall enterprise risk management (“ERM”) process. As a result, risks posed by cybersecurity threats are among the risks that the Company’s ERM process evaluates and assesses at least annually. The results of this risk assessment, including cybersecurity, are presented to the BOD annually.

The cybersecurity team implements, monitors and maintains controls that are aligned with the guidance defined by the National Institute of Standards and Technology CyberSecurity Framework. These controls are designed to protect the confidentiality, availability and integrity of information systems. Our cybersecurity processes include automated tools and technical safeguards managed and monitored by our cybersecurity team. We view cybersecurity as a responsibility shared by all of our associates. As an organization committed to continuous improvement, we periodically conduct incident response tabletop exercises with key members of our leadership team, including our Chief Executive Officer, perform internal and external assessments and engage consultants to help assess the design and effectiveness of our program. In addition, we expect all of our associates as well as our third-party vendors to help protect against cybersecurity risks, and we conduct periodic awareness campaigns, emerging threats communications and specific training.

We have adopted a Global Cybersecurity Incident Response Procedure that applies in the event of a cybersecurity threat or incident. These procedures include an incident response playbook that outlines the steps to be addressed in the event of a
cybersecurity incident, from incident detection to mitigation, recovery and notification within the Company and to the Audit Committee and/or BOD, as specified.

We also rely on information technology and third-party vendors to support our operations, including our secure processing of personal, confidential, sensitive, proprietary and other types of information. We employ systems and processes designed to oversee, identify and reduce the potential impact of a security incident at a third-party vendor, service provider or customer or otherwise implicating the third-party technology and systems we use. Despite ongoing efforts to continuously improve our holistic ability to protect against cyber incidents, we may not be able to protect all information systems, and such incidents may lead to reputational harm, disruption of our business operations, revenue and client loss, legal actions, or statutory penalties, among other consequences.

Due to evolving cybersecurity threats, it has and will continue to be difficult to prevent, detect, mitigate and remediate cybersecurity incidents. While we are not aware of any material cybersecurity threats or incidents that have had or are reasonably likely to materially affect us, including those having a long-term impact on our business strategy, results of operations or financial condition, there can be no guarantee that we will not be the subject of future successful attacks, threats or incidents. For additional information on the cybersecurity risks faced by our Company, refer to Item 1A. “Risk Factors—Risks Related to Our Business—Our electronic information systems have been and could in the future be, subject to service interruptions, data corruption, cyber-based attacks and network security breaches. Significant disruptions in, or breaches in security of, our electronic information systems or data can adversely affect our business and financial statements” and “Risk Factors—Risks Related to Our Business—Failure to successfully integrate new technologies, including artificial intelligence and machine learning, could limit our ability to grow and maintain our competitive position and adversely affect our financial condition, results of operations and cash flow” of this Form 10-K.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity related risks are integrated into our overall enterprise risk management (“ERM”) process. As a result, risks posed by cybersecurity threats are among the risks that the Company’s ERM process evaluates and assesses at least annually. The results of this risk assessment, including cybersecurity, are presented to the BOD annually
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The BOD maintains responsibility for oversight of risks that may affect the Company. Our BOD has delegated the primary responsibility to oversee cybersecurity matters to the Audit Committee. The Audit Committee reviews the Company’s policies with respect to risk assessment and enterprise risk management, including with respect to cybersecurity risks. Certain members of our Audit Committee have experience with respect to cybersecurity risk management.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
The BOD maintains responsibility for oversight of risks that may affect the Company. Our BOD has delegated the primary responsibility to oversee cybersecurity matters to the Audit Committee. The Audit Committee reviews the Company’s policies with respect to risk assessment and enterprise risk management, including with respect to cybersecurity risks. Certain members of our Audit Committee have experience with respect to cybersecurity risk management.

The Audit Committee regularly reviews the measures implemented by the Company to identify and mitigate data protection and cybersecurity risks. As part of such reviews, the Audit Committee receives reports and presentations from members of the Company’s management team responsible for overseeing the Company’s cybersecurity risk program, including our Chief Information Officer (“CIO”). These reports and updates may address a wide range of topics, including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends and information security considerations arising with respect to the Company’s peers and third parties. The Audit Committee periodically reports to the BOD on data protection and cybersecurity matters. We also have protocols by which certain cybersecurity incidents are escalated within the Company and, in certain circumstances, reported to the BOD and/or Audit Committee in a timely manner.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
The Audit Committee regularly reviews the measures implemented by the Company to identify and mitigate data protection and cybersecurity risks. As part of such reviews, the Audit Committee receives reports and presentations from members of the Company’s management team responsible for overseeing the Company’s cybersecurity risk program, including our Chief Information Officer (“CIO”). These reports and updates may address a wide range of topics, including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends and information security considerations arising with respect to the Company’s peers and third parties. The Audit Committee periodically reports to the BOD on data protection and cybersecurity matters. We also have protocols by which certain cybersecurity incidents are escalated within the Company and, in certain circumstances, reported to the BOD and/or Audit Committee in a timely manner.
At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.

In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Role of Management [Text Block]
At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.

In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Fiscal Period
The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th complete week after the end of the prior quarter.
Basis of Presentation
Use of Estimates
Use of Estimates
 
The Company makes certain estimates and assumptions in preparing its Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.
Equity Method Investments
Equity Method Investments
Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value.
Revenue Recognition
Revenue Recognition

The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services.

The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers, to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time.

As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information.

The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred.

Taxes Collected from Customers and Remitted to Governmental Authorities
 
The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority.
Research and Development Expense
Research and Development Expense
 
Research and development costs of $44.0 million, $39.2 million and $38.8 million for the years ended December 31, 2025, 2024 and 2023, respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects.
Cash and Cash Equivalents
Cash and Cash Equivalents
 
Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.
Trade Receivables
Trade Receivables
 
Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically.
Inventories
Inventories

Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. Cost of inventories is determined by costing methods that approximate a first-in, first-out (“FIFO”) method.

During the fourth quarter of 2024, the Company changed its inventory costing methodology from the last-in, first-out (“LIFO”) method to the FIFO method for a portion of its inventory. As of the year ended December 31, 2024, all inventory is valued under FIFO. The Company performed this change because it believes FIFO is preferable given it provides a more consistent method for valuing inventory across the Company, better matches costs with revenues, improves comparability with peers and better reflects the current value of inventory at the balance sheet date. The LIFO expense for the year ended December 31, 2023 was $2.1 million, which is not considered material to the Company’s financial statements. The Company recorded the pre-tax cumulative benefit related to this change in accounting principle of $4.3 million as a reduction of Cost of sales for the year ended December 31, 2024. Since these amounts are immaterial to all periods presented, the impact of this change was not retrospectively reflected in prior years.

Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $39.2 million and $41.2 million as of December 31, 2025 and 2024, respectively.
Property, Plant and Equipment
Property, Plant and Equipment
 
Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions and depreciated by the straight-line method over the estimated remaining useful lives of the related assets. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.
Impairment of Goodwill and Indefinite-Lived Intangible Assets
Impairment of Goodwill and Indefinite-Lived Intangible Assets
 
Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company.

 The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”).

In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value, not to exceed the amount of goodwill attributable to that reporting unit.

When a quantitative impairment test is performed, the Company measures fair value of reporting units based on a combination of the income approach and market approach. Under the income approach, the Company uses a discounted cash flow model that calculates the fair value as the present value of the cash flows of the reporting units. Under the market approach, the fair value of the business based on comparison against certain market information. Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, value of net operating losses, future economic and market conditions and determination of appropriate market comparables. Management bases fair value estimates on assumptions it believes to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from these estimates and the estimate is inherently sensitive to any material changes to the inputs noted above; these changes could potentially impact the fair value of reporting units.
For the year ended December 31, 2025, a quantitative goodwill impairment assessment was performed and for the years ended December 31, 2024 and 2023, a qualitative goodwill impairment assessment was performed for the three reporting units, all of which indicated no impairment existed and therefore, no impairment charges were recorded for the respective periods. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2025 annual impairment test.

In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. Any material deviation in actual results could affect the calculated fair value of the intangible asset. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade names for the years ended December 31, 2025, 2024 and 2023, all of which indicated no impairment existed.
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets
 
Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from five to thirty years.

The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2025, 2024 and 2023.
Derivatives
Derivatives

The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes.

All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued.

The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty.

The Company had certain interest rate swap agreements that were designated and qualified as cash flow hedges. The final swap matured on April 3, 2025. Therefore, the Company does not have any interest rate swaps outstanding as of the year ended December 31, 2025. The effective portion of the fair value of unrealized gain or loss on cash flow hedges was reported as a component of Accumulated other comprehensive loss ("AOCL") with offsetting amounts recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value was reclassified into earnings in the same period or periods during which the hedged
transaction affected earnings. If a derivative were deemed to be ineffective, the change in fair value of the derivative would be recognized directly in earnings.

The Company has certain cross-currency swap agreements that are designated and qualify as a net investment hedge. The changes in the fair value of these instruments are recorded in AOCL in equity partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract.

The Company has certain foreign currency contracts that are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense and other, net, in the Company’s Consolidated Statement of Operations.
Warranty Costs
Warranty Costs
 
Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims.
Income Taxes
Income Taxes
 
The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”), which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred.

Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets.

The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements.

The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated Statements of Operations.
Interest expense (income) and Other, Net
Interest Expense and Other, Net

Interest expense and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest expense of derivatives designated in hedging relationships. In addition, it is comprised of:
•other non-operating expense (income) items, including certain pension-related activities,
•foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships and
•Argentina highly inflationary accounting transaction exchange loss on cash and cash equivalents remeasured into the Brazilian real - the direct parent’s currency.
See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information.
Foreign Currency Exchange Gains and Losses
Foreign Currency Exchange Gains and Losses
 
The Company’s Consolidated Financial Statements are presented in U.S. Dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation in Equity are net of income taxes to the extent the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense and other, net in the Consolidated Statements of Operations for that period.
Recently Issued Accounting Pronouncements Recently Issued Accounting Pronouncements
The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated Financial Statements as well as material updates to previous assessments.

Accounting Guidance Implemented in 2025

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”), which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company has adopted this guidance for the year ended December 31, 2025, refer to Note 8. “Income Taxes” for further information on the impact on the Company’s disclosures.

Recently Issued Accounting Guidance Not Yet Adopted

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which expands disclosure requirements for more detailed information about the types of expenses in commonly presented expense captions. The ASU is effective for fiscal years beginning after December 15, 2026. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.
v3.25.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Net Foreign Transaction Gains and Losses
The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated Statements of Operations.
Year Ended December 31,
202520242023
(In thousands)(1)
Selling, general and administrative expense$(425)$7,136 $11,389 
Interest expense and other, net2,777 (158)1,719 
Foreign currency transaction loss, net(2)
$2,352 $6,978 $13,108 
(1) This table excludes the foreign currency exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations, as described in the “Argentina Highly Inflationary Accounting” paragraph below.
(2) During 2023, the weakening of the Ruble and certain South American currencies drove the increase in the loss on transactions denominated in foreign currencies.
v3.25.4
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2025
Business Combination [Abstract]  
Business Combination, Recognized Asset Acquired and Liability Assumed
The following table summarizes the preliminary allocation of the purchase price to the assets acquired and liabilities assumed for the year ended December 31, 2025. These amounts, including inventory, property, plant and equipment, intangible assets and deferred taxes are determined based upon certain valuations and studies that have yet to be finalized. Accordingly, the assets acquired and liabilities assumed, as detailed below, are subject to adjustment once the detailed analyses are completed.
EWMAll OthersTotal
(In thousands)
Cash and cash equivalents$10,360 $6,803 $17,163 
Inventories, net40,081 7,662 47,743 
Property, plant and equipment, net51,481 6,284 57,765 
Goodwill(1)
153,567 63,562 217,129 
Intangible assets129,746 46,656 176,402 
Deferred tax liability(38,224)(12,443)(50,667)
Other, net(2)
(12,271)(890)(13,161)
Purchase price consideration$334,740 $117,634 $452,374 
(1) Goodwill for “All Others” includes approximately $39 million for Bavaria and $16 million for Aktiv.
(2) Includes current and non-current amounts and non-controlling interest.

The following table summarizes the values of the significant identifiable intangible assets acquired, excluding Goodwill, for the year ended December 31, 2025:
EWMAll Others
Intangible AssetAmortization PeriodIntangible AssetWeighted-Average Amortization Period
(In thousands)(In years)(In thousands)(In years)
Customer relationships(1)
$89,095 20$37,984 17
Trade names20,536 106,484 10
Technology and other20,115 102,188 5
$129,746 $46,656 
(1) Customer relationships for “All Others” includes approximately $23 million for Bavaria with an amortization period of 18 years.
v3.25.4
Revenue (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The Company disaggregates its revenue into the product groups:
Year Ended December 31,
202520242023
(In thousands)
Equipment$971,994 $893,313 $854,949 
Consumables1,870,561 1,847,490 1,919,817 
$2,842,555 $2,740,803 $2,774,766 
Schedule of Accounts Receivable, Allowance for Credit Loss the activity in the Company’s Allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets.
Year Ended December 31, 2025
Balance at Beginning of PeriodCharged to Expense, netWrite-Offs and DeductionsForeign Currency TranslationBalance at
End of Period
(In thousands)
Allowance for credit losses $23,850 $(173)$(3,307)$1,395 $21,765 
v3.25.4
Earnings per Share from Continuing Operations (Tables)
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share from Continuing Operations The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Year Ended December 31,
202520242023
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation(1)
$252,637 $287,151 $217,626 
Distributed and undistributed earnings allocated to nonvested shares(1,218)(1,370)(1,555)
Income from continuing operations attributable to common stockholders$251,419 $285,781 $216,071 
Weighted-average shares of Common stock outstanding – basic
60,680,448 60,427,743 60,233,623 
Income per share from continuing operations – basic
$4.14 $4.73 $3.59 
Computation of earnings per share from continuing operations – diluted:
Income from continuing operations attributable to common stockholders$251,419 $285,781 $216,071 
Weighted-average shares of Common stock outstanding – basic
60,680,448 60,427,743 60,233,623 
Net effect of potentially dilutive securities(2)
585,846 674,320 422,123 
Weighted-average shares of Common stock outstanding – dilution
61,266,294 61,102,063 60,655,746 
Net income per share from continuing operations – diluted
$4.10 $4.68 $3.56 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $6.5 million, $5.9 million and $5.7 million for the years ended December 31, 2025, 2024 and 2023, respectively.
(2) Potentially dilutive securities include stock options, performance-based restricted stock units and nonperformance-based restricted stock units.
v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. The classification of tax expense between federal, state and foreign has been recast for prior years to make all years comparable after the adoption of ASU 2023-09.
Year Ended December 31,
202520242023
(In thousands)
Income from continuing operations before income taxes:  
Domestic operations$36,517 $50,212 $37,364 
Foreign operations291,743320,193281,728
328,260 370,405 319,092 
Income tax expense:
Current:
Federal7,566 8,983 12,548 
State1,929 2,6353,760
Foreign91,188 65,495104,522
100,68377,113120,830
Deferred:
Federal(4,381)4,043 (11,897)
State(14)(126)(1,341)
Foreign(27,131)(3,682)(11,865)
(31,526)235 (25,103)
$69,157 $77,348 $95,727 
Schedule of Components of Income Tax Expense (Benefit)
Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. The classification of tax expense between federal, state and foreign has been recast for prior years to make all years comparable after the adoption of ASU 2023-09.
Year Ended December 31,
202520242023
(In thousands)
Income from continuing operations before income taxes:  
Domestic operations$36,517 $50,212 $37,364 
Foreign operations291,743320,193281,728
328,260 370,405 319,092 
Income tax expense:
Current:
Federal7,566 8,983 12,548 
State1,929 2,6353,760
Foreign91,188 65,495104,522
100,68377,113120,830
Deferred:
Federal(4,381)4,043 (11,897)
State(14)(126)(1,341)
Foreign(27,131)(3,682)(11,865)
(31,526)235 (25,103)
$69,157 $77,348 $95,727 
Schedule of Effective Income Tax Rate Reconciliation
The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows in the table below.
Year Ended December 31,
2025
(Dollars in thousands)
 United States federal statutory tax $68,950 21.0 %
 State and local income tax, net of federal income tax effect(1)
1,510 0.5 %
 Foreign tax effects:
    United Kingdom:
       Valuation allowance (11,965)(3.7)%
       Other 1,147 0.4 %
    Switzerland:
       Statutory tax rate difference between Switzerland and United States (5,913)(1.8)%
       Other (2,286)(0.7)%
    Peru 5,248 1.6 %
    Other foreign jurisdictions 19,651 6.0 %
 Effect of changes in tax laws or rates enacted in the current period — — %
 Effect of cross-border tax laws:
    Global Intangible Low-Taxed Income inclusion 24,828 7.6 %
    Subpart F income inclusion 9,663 2.9 %
    Foreign-Derived Intangible Income deduction (5,563)(1.7)%
    Foreign tax credit (33,516)(10.2)%
    Other (93)— %
 Tax credits (916)(0.3)%
 Changes in valuation allowances (1,555)(0.5)%
 Nontaxable or nondeductible items:
    Nondeductible officer compensation 4,762 1.5 %
    Other (1,250)(0.4)%
 Changes in unrecognized tax benefits (2,897)(0.9)%
 Other adjustments (646)(0.2)%
$69,157 21.1 %
(1) State taxes in California, Illinois, Kentucky, Louisiana, Minnesota, New York and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in this category.
The following table presents the required disclosures prior to our adoption of ASU 2023-09 and reconciles the taxes calculated at the United States federal statutory tax rate to the total income tax expense for the years ended December 31, 2024 and 2023.
Year Ended December 31,
20242023
(In thousands)
Taxes calculated at the United States federal statutory rate$77,785 $67,010 
State taxes1,956 1,630 
Effect of tax rates on international operations1,823 1,548 
Changes in tax reserves(4,206)10,753 
Research and development tax credits(980)(714)
Effect of United States taxation on international operations5,239 1,527 
Permanent differences, net
(4,061)10,077 
Provision to return(8,350)703 
Withholding taxes6,634 11,172 
Valuation Allowance(761)(12,308)
Other2,269 4,329 
Income tax expense$77,348 $95,727 
Schedule of Deferred Tax Assets and Liabilities The table below shows the temporary differences that gave rise to the significant components of deferred tax assets and liabilities.
December 31,
20252024
(In thousands)
Deferred tax assets:
Post-retirement benefit obligation$1,894 $1,229 
Expenses currently not deductible73,063 59,518 
Net operating loss carryforward90,458 86,716 
Tax credit carryforward8,323 5,137 
Depreciation and amortization6,544 4,286 
Inventory12,892 10,795 
Capitalized R&D costs 22,035 20,556 
Leases27,831 21,490 
Net investment hedge10,859 — 
Valuation allowance(54,883)(65,007)
Deferred tax assets, net199,016 144,720 
Deferred tax liabilities:
Depreciation and amortization(183,201)(125,227)
Leases(28,418)(22,084)
Outside basis differences and other(87,959)(87,434)
Total deferred tax liabilities(299,578)(234,745)
Total deferred tax liabilities, net$(100,562)$(90,025)

Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as broken out in the table below.
December 31,
20252024
(In thousands)
Other assets$58,217 $44,816 
Other liabilities(158,779)(134,841)
Deferred tax liability, net$(100,562)$(90,025)
Schedule of Unrecognized Tax Benefits Roll Forward
The table below includes a reconciliation of the beginning and ending amount of gross unrecognized tax benefits (inclusive of associated interest and penalties).
(In thousands)
Balance, January 1, 2023
$20,203 
Addition for tax positions taken in prior periods13,514 
Reductions related to settlements with taxing authorities(4,160)
Other, including the impact of foreign currency translation1,314 
Balance, December 31, 2023
30,871 
Addition for tax positions taken in prior periods6,436 
Reductions for tax positions taken in prior periods(7,825)
Reductions related to settlements with taxing authorities(9,255)
Reductions resulting from a lapse of applicable statute of limitations(51)
Other, including the impact of foreign currency translation(3,092)
Balance, December 31, 2024
17,084 
Addition for tax positions taken in prior periods7,300 
Reductions for tax positions taken in prior periods(2,201)
Reductions related to settlements with taxing authorities(3,624)
Reductions resulting from a lapse of applicable statute of limitations(1,484)
Other, including the impact of foreign currency translation1,513 
Balance, December 31, 2025
$18,588 
Schedule of Cash Flow, Supplemental Disclosures
The table below includes a breakout of income taxes paid for the year ended December 31, 2025.
Year Ended December 31,
2025
(In thousands)
Federal$872 
State1,439 
Foreign90,379 
$92,690 
Income taxes paid (net of refunds) exceeded 5 percent of total income taxes paid (net of refunds) in the following jurisdictions:
Foreign:
India$11,833 
Brazil11,537 
Switzerland8,724 
China8,572 
United Kingdom6,765 
Peru6,003 
Czech Republic5,798 
Mexico5,039 
v3.25.4
Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes Goodwill activity by segment for the years ended December 31, 2025 and 2024.
 Americas
EMEA & APAC
Total
 (In thousands)
Balance, January 1, 2024
$589,875 $998,456 $1,588,331 
Goodwill attributable to acquisition(1)
44,505 46,691 91,196 
Impact of foreign currency translation(4,675)(22,859)(27,534)
Balance, December 31, 2024
629,705 1,022,288 1,651,993 
Goodwill attributable to acquisitions(1)
2,500 217,128 219,628 
Impact of foreign currency translation14,812 63,269 78,081 
Balance, December 31, 2025
$647,017 $1,302,685 $1,949,702 
Schedule of Indefinite-Lived Intangible Assets
The following table summarizes the Company’s Intangible assets, excluding Goodwill.
 December 31,
 20252024
 Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets:
Trade names$197,120 $— $173,912 $— 
Definite-Lived Intangible Assets:
Customer relationships661,002 (288,727)506,226 (248,920)
Technology101,214 (64,631)71,912 (55,539)
Trade names58,553 (16,428)28,878 (11,832)
Software91,802 (73,731)78,122 (62,391)
Other intangible assets31,219 (24,387)30,424 (22,799)
 $1,140,910 $(467,904)$889,474 $(401,481)
Schedule of Finite-Lived Intangible Assets
The following table summarizes the Company’s Intangible assets, excluding Goodwill.
 December 31,
 20252024
 Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
 (In thousands)
Indefinite-Lived Intangible Assets:
Trade names$197,120 $— $173,912 $— 
Definite-Lived Intangible Assets:
Customer relationships661,002 (288,727)506,226 (248,920)
Technology101,214 (64,631)71,912 (55,539)
Trade names58,553 (16,428)28,878 (11,832)
Software91,802 (73,731)78,122 (62,391)
Other intangible assets31,219 (24,387)30,424 (22,799)
 $1,140,910 $(467,904)$889,474 $(401,481)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
The Company’s expected annual amortization expense for intangible assets for the next five years is as follows.
 December 31, 2025
 (In thousands)
2026$43,037 
202738,989 
202836,106 
202934,794 
203032,888 
v3.25.4
Property, Plant and Equipment, Net (Tables)
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
  December 31,
 Depreciable Life20252024
 (In years)(In thousands)
Landn/a$23,481 $14,484 
Buildings and improvements
5-40
233,850 176,077 
Machinery and equipment
3-15
486,676 409,045 
  744,007 599,606 
Accumulated depreciation (362,131)(301,259)
 $381,876 $298,347 
v3.25.4
Inventories, Net (Tables)
12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventory
December 31,
20252024
(In thousands)
Raw materials$173,458 $151,248 
Work in process40,033 41,698 
Finished goods307,517 251,994 
521,008 444,940 
Less: allowance for excess, slow-moving and obsolete inventory(39,243)(41,229)
$481,765 $403,711 
v3.25.4
Leases (Tables)
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Future Minimum Lease Payments
December 31, 2025
(In thousands)
Future lease payments by year:
2026$28,379 
202726,093 
202819,582 
202914,418 
203012,754 
Thereafter50,245 
151,471 
Less: present value discount(41,249)
Present value of lease liabilities$110,222 
Weighted-average remaining lease term (in years):
Operating leases7.1
Weighted-average discount rate:
Operating leases8.5 %
v3.25.4
Accrued and Other Liabilities (Tables)
12 Months Ended
Dec. 31, 2025
Accrued Liabilities [Abstract]  
Schedule of Accrued and Other Liabilities Accrued liabilities and Other liabilities in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$53,728 $182,898 $46,395 $151,642 
Compensation and related benefits68,53552,70680,45148,350
Asbestos liability 42,242269,82940,779253,287
Contract liability19,663—26,390—
Lease liability22,08188,14121,45966,042
Warranty liability 12,573—12,794—
Third-party commissions19,371—17,346—
Restructuring liability17,2973194,732374
Accrued interest8,570—8,077—
Other37,92663,34340,13513,241
$301,986 $657,236 $298,558 $532,936 
Schedule of Product Warranty Liability
The table below summarizes the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets.
Year Ended December 31,
20252024
(In thousands)
Warranty liability, beginning of period$12,794 $12,606 
Accrued warranty expense8,926 10,570 
Changes in estimates related to pre-existing warranties762 1,624 
Cost of warranty service work performed(12,146)(11,426)
Foreign exchange translation effect and other2,237 (580)
Warranty liability, end of period$12,573 $12,794 
Schedule of Restructuring Reserve by Type of Cost The table below summarizes the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets.
Year Ended December 31, 2025
Balance at Beginning of PeriodChargesPaymentsForeign Currency Translation and OtherBalance at End of Period
(In thousands)
Termination benefits(1)
$3,845 $19,174 $(8,678)$709 $15,050 
Facility closure costs and other(2)
1,261 8,582 (6,245)(1,032)2,566 
$5,106 $27,756 $(14,923)$(323)$17,616 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment and other costs in connection with the closure and optimization of facilities and product lines.

Year Ended December 31, 2024
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Termination benefits(1)
$4,595 $4,538 $(5,288)$— $3,845 
Facility closure costs(2)
1,104 5,689 (5,112)(420)1,261 
$5,699 $10,227 $(10,400)$(420)$5,106 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expenses and other costs in connection with the closure and optimization of facilities and product lines.
v3.25.4
Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Changes in Projected Benefit Obligations
The following table summarizes the total changes in the Company’s total and foreign pension benefits and plan assets and includes a statement of the plans’ funded status.
 All Pension BenefitsForeign Pension Benefits
 Year Ended December 31,Year Ended December 31,
 2025202420252024
 (In thousands)
Change in benefit obligation:    
Projected benefit obligation, beginning of year$189,874 $242,743 $63,898 $99,215 
Service cost1,466 1,429 1,466 1,429 
Interest cost8,475 8,828 2,513 2,576 
Plan amendments1,671 (9)1,671 (9)
Actuarial loss (gain)1,109 (5,945)(1,721)1,178 
Foreign exchange effect8,112 (5,386)8,112 (5,386)
Benefits paid(17,533)(21,242)(4,760)(4,561)
Settlements(1,314)(31,583)(1,314)(31,583)
Other4,759 1,039 4,759 1,039 
Projected benefit obligation, end of year196,619 189,874 74,624 63,898 
Accumulated benefit obligation, end of year192,972 186,689 70,977 60,713 
Change in plan assets:
Fair value of plan assets, beginning of year161,906 211,472 21,894 65,278 
Actual return on plan assets8,657 12,389 1,068 2,024 
Employer contributions4,874 4,309 4,750 4,175 
Foreign exchange effect1,930 (2,028)1,930 (2,028)
Benefits paid(17,533)(21,242)(4,760)(4,561)
Settlements(1,314)(43,283)(1,314)(43,283)
Other3,809 289 3,809 289 
Fair value of plan assets, end of year162,329 161,906 27,377 21,894 
Funded status, end of year(34,290)(27,968)(47,247)(42,004)
Amounts recognized on the Consolidated Balance Sheets as of December 31:
Non-current assets16,194 17,228 2,164 2,072 
Current liabilities(4,039)(3,113)(3,914)(2,979)
Non-current liabilities(46,445)(42,083)(45,497)(41,097)
$(34,290)$(27,968)$(47,247)$(42,004)
Schedule of Expected Benefit Payments The table below includes the benefit payments that are expected to be paid during each respective fiscal year.
 Pension Benefits
 All PlansForeign Plans
 (In thousands)
2026$20,672 $7,685 
202719,078 6,525 
202818,208 6,063 
202917,878 6,229 
203017,812 6,666 
2031 – 203577,553 29,705 
Schedule of Allocation of Plan Assets
The table below shows the actual allocation percentages for the Company’s pension plan assets.
 Actual Asset Allocation
December 31,
 20252024
United States Plans:
Equity securities:
United States— %37 %
International— %13 %
Fixed income90 %50 %
Cash and cash equivalents10 %— %
Foreign Plans:
Equity securities— %4 %
Fixed income14 %15 %
Cash and cash equivalents1 %1 %
Insurance contracts51 %44 %
Investment funds(1)
34 %36 %
 
(1) Represents various fixed income and equity securities.
The table below summarizes the Company’s pension plan assets for each fair value hierarchy level for the periods presented (see Note 17, “Fair Value Measurements” for further description of the levels within the fair value hierarchy).
 December 31, 2025December 31, 2024
 
Measured at Net Asset Value (1)
Level
One
Level
Two
Level
Three
 
Total
Measured at Net Asset Value(1)
Level
One
Level
Two
Level
Three
 
Total
 (In thousands)
United States Plans:
Cash and cash equivalents $— $13,097 $— $— $13,097 $— $379 $— $— $379 
Equity securities:
United States large cap— — — — — 28,803 — — — 28,803 
United States small/mid cap— — — — — 9,456 13,481 — — 22,937 
International— — — — — 17,566 — — — 17,566 
Fixed income mutual funds:
United States government and corporate121,856 — — — 121,856 69,152 — — — 69,152 
Other — — — — — — 1,175 — — 1,175 
Foreign Plans:
Cash and cash equivalents(2)
— 237 — — 237 — 238 — — 238 
Equity securities— 95 — — 95 — 904 — — 904 
Non-United States government and corporate bonds— 3,679 — — 3,679 — 3,198 — — 3,198 
Insurance contracts— — 14,040 — 14,040 — — 9,608 — 9,608 
Investment funds— — 9,298 — 9,298 — — 7,919 — 7,919 
Other— — 27 — 27 — — 27 — 27 
 $121,856 $17,108 $23,365 $— $162,329 $124,977 $19,375 $17,554 $— $161,906 
(1)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term.
(2)The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
Schedule of Net Benefit Costs
The following table sets forth the components of net periodic benefit cost and Other comprehensive income (loss) of the Company’s total and foreign defined benefit pension plans.
 All Pension BenefitsForeign Pension Benefits
 Year Ended December 31,Year Ended December 31,
 202520242023202520242023
 (In thousands)
Components of Net Periodic Benefit Cost:    
Service cost$1,466 $1,429 $1,439 $1,466 $1,429 $1,439 
Interest cost8,475 8,828 11,170 2,513 2,576 4,148 
Amortization1,500 1,634 1,206 155 130 40 
Settlement loss(1)
— 12,155 — — 12,155 — 
Other122 (179)— 122 (179)(331)
Expected return on plan assets(7,917)(9,410)(11,391)(881)(1,038)(2,475)
Net periodic benefit cost3,646 14,457 2,424 3,375 15,073 2,821 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Current year net actuarial loss (gain)1,501 (9,598)(7,021)(777)(483)1,984 
Current year prior service cost (income)1,620 (9)175 1,620 (9)175 
Less amounts included in net periodic benefit cost:
Amortization of net loss(1,506)(1,676)(1,575)(161)(172)(78)
Settlement / divestiture / other loss(114)(455)(1,079)(114)(454)(1,079)
Amortization of prior service cost (income)6 42 38 6 42 38 
Total recognized in Other comprehensive income (loss)$1,507 $(11,696)$(9,462)$574 $(1,076)$1,040 
 
(1)During the year ended December 31, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan.
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
The following table sets forth the components of net periodic benefit cost and Other comprehensive income (loss) of the Company’s total and foreign defined benefit pension plans.
 All Pension BenefitsForeign Pension Benefits
 Year Ended December 31,Year Ended December 31,
 202520242023202520242023
 (In thousands)
Components of Net Periodic Benefit Cost:    
Service cost$1,466 $1,429 $1,439 $1,466 $1,429 $1,439 
Interest cost8,475 8,828 11,170 2,513 2,576 4,148 
Amortization1,500 1,634 1,206 155 130 40 
Settlement loss(1)
— 12,155 — — 12,155 — 
Other122 (179)— 122 (179)(331)
Expected return on plan assets(7,917)(9,410)(11,391)(881)(1,038)(2,475)
Net periodic benefit cost3,646 14,457 2,424 3,375 15,073 2,821 
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Current year net actuarial loss (gain)1,501 (9,598)(7,021)(777)(483)1,984 
Current year prior service cost (income)1,620 (9)175 1,620 (9)175 
Less amounts included in net periodic benefit cost:
Amortization of net loss(1,506)(1,676)(1,575)(161)(172)(78)
Settlement / divestiture / other loss(114)(455)(1,079)(114)(454)(1,079)
Amortization of prior service cost (income)6 42 38 6 42 38 
Total recognized in Other comprehensive income (loss)$1,507 $(11,696)$(9,462)$574 $(1,076)$1,040 
 
(1)During the year ended December 31, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan.
Schedule of Net Periodic Benefit Cost Not yet Recognized
The table below shows the components of net unrecognized pension benefit cost included in AOCL in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost.
 December 31,
 20252024
 (In thousands)
Net actuarial loss$49,797 $49,917 
Prior service cost (income)1,505 (122)
$51,302 $49,795 
Schedule of Assumptions Used
The key economic assumptions used in the measurement of the Company’s pension benefit obligations are included in the table below.
 December 31,
 20252024
Weighted-average discount rate:  
All plans4.7 %4.8 %
Foreign plans4.3 %3.7 %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.5 %3.1 %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
The key economic assumptions used in the computation of net periodic benefit cost are as included in the table below.
 Year Ended December 31,
 202520242023
Weighted-average discount rate:  
All plans4.8 %4.4 %4.6 %
Foreign plans3.7 %3.9 %4.3 %
Weighted-average expected return on plan assets:
All plans4.8 %5.1 %5.0 %
Foreign plans4.1 %4.4 %4.1 %
Weighted-average rate of increase in compensation levels for active foreign plans(1)
3.1 %3.1 %3.2 %
 
(1)Weighted-average rate of increase is only applicable to plans with compensation increase assumptions.
v3.25.4
Debt (Tables)
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt debt.
December 31,
20252024
(In thousands)
Term loan$350,000 $385,000 
Senior unsecured notes700,000 700,000 
Revolving credit facility185,000 — 
Other debt8,215 — 
Total debt1,243,215 1,085,000 
Current portion of debt(2,412)(15,000)
Unamortized deferred financing fees(8,263)(9,261)
Long-term debt$1,232,540 $1,060,739 
Schedule of the Contractual Maturities of the Company's Debt
The Company’s minimum principal payments for the next five years are broken out in the table below.
December 31, 2025
(In thousands)
2026$2,412 
202710,408 
202810,408 
2029719,158 
2030500,829 
Total debt(1)
$1,243,215 
 
(1)Total debt excludes $8.3 million of related unamortized deferred financing fees.
v3.25.4
Derivatives (Tables)
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets.
December 31, 2025
December 31, 2024
Designated as hedging instrumentsOther LiabilitiesOther AssetsOther LiabilitiesOther Assets
(In thousands)
Cross-currency swap agreements $48,778 $— $1,830 $— 
Interest rate swap agreement— — — 842 
$48,778 $— $1,830 $842 
Derivatives Not Designated as Hedging Instruments
The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets.
December 31, 2025
December 31, 2024
Not designated as hedging instrumentsAccrued LiabilitiesOther Current AssetsAccrued LiabilitiesOther Current Assets
(In thousands)
Foreign currency contracts$183 $780 $379 $255 
v3.25.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is in the table below (see Note 14, “Benefit Plans” for classification of the assets of the Company’s benefit plans within the fair value hierarchy).
December 31, 2025December 31, 2024
Level
One
Level
Two
Level
Three
TotalLevel
One
Level
Two
Level
Three
Total
(In thousands)
Assets:
Cash equivalents$11,965 $— $— $11,965 $8,990 $— $— $8,990 
Foreign currency contracts— 857 — 857 — 657 — 657 
Interest rate swap agreement— — — — — 842 — 842 
Deferred compensation plans— 7,214 — 7,214 — 5,242 — 5,242 
11,965 8,071 — 20,036 8,990 6,741 — 15,731 
Liabilities:
Foreign currency contracts— 260 — 260 — 781 — 781 
Cross-currency swap agreements— 48,778 — 48,778 — 1,830 — 1,830 
Deferred compensation plans— 7,214 — 7,214 — 5,242 — 5,242 
$— $56,252 $— $56,252 $— $7,853 $— $7,853 
v3.25.4
Equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The following table presents the changes in the balances of each component of AOCL including reclassifications out of AOCL for the years ended December 31, 2025, 2024 and 2023. All amounts are net of tax and noncontrolling interest, if any.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at January 1, 2023
$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
Other comprehensive income (loss) before reclassifications:
Net actuarial gain8,969 — — — 8,969 
Foreign currency translation adjustment(3,285)(11,143)(8,879)— (23,307)
Gain on long-term intra-entity foreign currency transactions— 70,428 — — 70,428 
Unrealized gain on cash flow hedges— — — 4,834 4,834 
Other comprehensive income (loss) before reclassifications5,684 59,285 (8,879)4,834 60,924 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
(1,642)— — (8,566)(10,208)
Net current period Other comprehensive income (loss)4,042 59,285 (8,879)(3,732)50,716 
Balance at December 31, 2023
(59,805)(554,622)(17,215)7,370 (624,272)
Other comprehensive income (loss) before reclassifications:
Net actuarial gain9,069 — — — 9,069 
Foreign currency translation adjustment530 (137,599)15,968 — (121,101)
Gain on long-term intra-entity foreign currency transactions— 14,136 — — 14,136 
Unrealized gain on cash flow hedges— — — 4,426 4,426 
Other comprehensive income (loss) before reclassifications9,599 (123,463)15,968 4,426 (93,470)
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
(146)— — (9,980)(10,126)
Purchase related to noncontrolling interest— (1,706)— — (1,706)
Net current period Other comprehensive income (loss)9,453 (125,169)15,968 (5,554)(105,302)
Balance at December 31, 2024
(50,352)(679,791)(1,247)1,816 (729,574)
Other comprehensive (loss) income before reclassifications:
Net actuarial loss(1,811)— — — (1,811)
Foreign currency translation adjustment(899)224,018 (36,467)— 186,652 
Gain on long-term intra-entity foreign currency transactions— 5,448 — — 5,448 
Unrealized gain on cash flow hedges— — — 16 16 
Other comprehensive (loss) income before reclassifications(2,710)229,466 (36,467)16 190,305 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
1,385 — — (1,832)(447)
Net current period Other comprehensive (loss) income(1,325)229,466 (36,467)(1,816)189,858 
Balance at December 31, 2025
$(51,677)$(450,325)$(37,714)$— $(539,716)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details.
(2) The amounts on this line within the Cash Flow Hedges column are a component of Interest expense and other, net. See Note 16, “Derivatives,” for additional details.
Schedule of Nonvested Share Activity
The activity of the Company’s PRSUs and RSUs is included in the table below.
 PRSUsRSUs
 Number of UnitsWeighted- Average
Grant-Date Fair Value
Number of UnitsWeighted-Average
Grant-Date Fair Value
Balance at December 31, 2024
200,642 $68.44 373,620 $67.02 
Granted100,947 131.81 129,729 123.38 
Vested93,799 49.43 173,517 62.38 
Forfeited and expired20,231 90.83 31,235 87.65 
Balance at December 31, 2025
187,559 $97.48 298,597 $92.20 
v3.25.4
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule Of Loss Contingencies By Claims Quantities Asbestos-related claims activity for the years ended December 31, 2025 and 2024, respectively.
Year Ended December 31,
20252024
(Number of claims)
Claims unresolved, beginning of period13,758 13,648 
Claims filed(1)
5,279 5,005 
Claims resolved(2)
(4,201)(4,895)
Claims unresolved, end of period14,836 13,758 
(In dollars)
Average cost of resolved claims(3)
$12,018 $10,574 
(1) Claims filed include all asbestos claims for which notification has been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.
(3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.
Schedule Of Asbestos Related Litigation Company’s Consolidated Balance Sheets include the amounts related to asbestos-related litigation shown in the table below.
December 31,
20252024
(In thousands)
Long-term asbestos insurance asset(1)
$235,361 $234,951 
Long-term asbestos insurance receivable(1)
16,811 16,961 
Accrued asbestos liability(2)
42,242 40,779 
Long-term asbestos liability(3)
269,829 253,287 
(1) Included in Other assets in the Consolidated Balance Sheets.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.
(3) Included in Other liabilities in the Consolidated Balance Sheets.
v3.25.4
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The Company’s segment results are included in the table below.
Year Ended December 31,
202520242023
(In thousands)
Net sales(1):
Americas$1,130,338 $1,176,745 $1,214,998 
EMEA & APAC1,712,217 1,564,058 1,559,768 
2,842,555 2,740,803 2,774,766 
Cost of sales:
Americas693,108 711,082 760,134 
EMEA & APAC1,101,105 992,266 998,881 
1,794,213 1,703,348 1,759,015 
Allocated operating expense:
Americas51,057 64,517 64,668 
EMEA & APAC93,724 97,807 103,984 
144,781 162,324 168,652 
Other operating expense:
Americas160,805 161,946 165,454 
EMEA & APAC183,046 184,411 180,543 
343,851 346,357 345,997 
Adjusted EBITDA(2):
Americas225,368 239,200 224,742 
EMEA & APAC334,342 289,574 276,360 
559,710 528,774 501,102 
Depreciation, amortization and other impairment charges:
Americas34,050 30,813 34,589 
EMEA & APAC50,055 35,977 40,445 
84,105 66,790 75,034 
Capital expenditures:
Americas18,791 22,645 21,576 
EMEA & APAC28,496 29,134 26,602 
$47,287 $51,779 $48,178 
(1) For the years ended December 31, 2025, 2024 and 2023, the total Net sales originating from the United States were $579.3 million, $595.6 million and $619.1 million, respectively.
(2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA on a consolidated basis:
Year Ended December 31,
202520242023
(In thousands)
Net income from continuing operations$259,103 $293,057 $223,365 
Income tax expense69,157 77,34895,727
Interest expense and other, net83,910 64,890 85,074 
Pension settlement loss— 12,155 — 
Restructuring and other related charges(1)
27,756 10,227 24,110 
Acquisition - amortization and other related charges(2)
72,063 34,479 36,851 
Depreciation and other amortization47,721 36,618 35,975 
Adjusted EBITDA$559,710 $528,774 $501,102 
(1) Includes severance and other termination benefits, including outplacement services, as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(2) Includes transaction, diligence and integration expenses totaling $31.5 million, $4.2 million and $2.6 million for the years ended December 31, 2025, 2024 and 2023, respectively, and amortization of intangibles and fair value charges on acquired inventories totaling $40.5 million, $30.3 million and $34.2 million for the years ended December 31, 2025, 2024 and 2023, respectively.

The Company’s investments in equity method investees and total assets by segment are included in the table below.
December 31,
20252024
(In thousands)
Investments in equity method investees:
Americas$— $— 
EMEA & APAC29,558 28,885 
29,558 28,885 
Total assets:
Americas1,717,390 1,796,167 
EMEA & APAC3,048,704 2,237,808 
$4,766,094 $4,033,975 
Schedule of Long-Lived Assets, by Geographical Areas
December 31,
20252024
(In thousands)
Property, plant and equipment, net(1):
Czech Republic$75,028 $55,554 
United States72,617 73,036 
Germany48,245 11,191 
India31,437 31,506 
Mexico23,464 20,495 
Other foreign countries131,085 106,565 
$381,876 $298,347 
(1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.
v3.25.4
Organization and Basis of Presentation (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Concentration Risk [Line Items]    
Number of reportable segments | segment 2  
Net income $ 226,766 $ 264,842
Stockholders' Equity Attributable to Parent (2,166,040) (1,769,004)
Cash and cash equivalents 185,863 $ 249,358
Foreign Currency Translation Adjustment    
Concentration Risk [Line Items]    
Stockholders' Equity Attributable to Parent 110,000  
RUSSIAN FEDERATION    
Concentration Risk [Line Items]    
Net income 9,000  
Cash and cash equivalents $ 50,000  
RUSSIAN FEDERATION | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk (as a percent) 5.00%  
RUSSIAN FEDERATION | Assets, Total | Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk (as a percent) 5.00%  
v3.25.4
Summary of Significant Accounting Policies - Narrative (Details)
12 Months Ended
Dec. 31, 2025
USD ($)
reporting_unit
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Incremental costs of obtaining a contract, period 1 year    
Research and development costs $ 44,000,000.0 $ 39,200,000 $ 38,800,000
LIFO expense amount     2,100,000
Cost of sales 1,794,213,000 1,703,348,000 1,759,015,000
Reserve for excess and obsolete inventory $ 39,243,000 41,229,000  
Number of reporting units | reporting_unit 3    
Goodwill impairment $ 0 0 0
Foreign exchange gain (loss) 2,352,000 6,978,000 13,108,000
Cumulative Effect, Period of Adoption, Adjustment      
Cost of sales   4,300,000  
Trade names      
Impairment of intangible assets, indefinite-lived 0 0 0
Selling, general and administrative expense      
Foreign exchange gain (loss) (425,000) 7,136,000 11,389,000
Interest expense and other, net      
Foreign exchange gain (loss) 2,777,000 (158,000) 1,719,000
Argentina, Pesos | Cost of Sales      
Foreign exchange gain (loss) 5,200,000 8,900,000 11,500,000
Argentina, Pesos | Selling, general and administrative expense      
Foreign exchange gain (loss) 4,600,000 600,000 6,700,000
Argentina, Pesos | Interest expense and other, net      
Foreign exchange gain (loss) $ 1,000,000.0 $ 300,000 $ 26,200,000
Minimum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements      
Intangible asset, useful life (in years) 5 years    
Maximum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements      
Intangible asset, useful life (in years) 30 years    
v3.25.4
Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) $ 2,352 $ 6,978 $ 13,108
Selling, general and administrative expense      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) (425) 7,136 11,389
Selling, general and administrative expense | Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) 4,600 600 6,700
Interest expense and other, net      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) 2,777 (158) 1,719
Interest expense and other, net | Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) 1,000 300 26,200
Cost of Sales | Argentina, Pesos      
Change in Accounting Estimate [Line Items]      
Foreign currency transaction loss, net(2) $ 5,200 $ 8,900 $ 11,500
v3.25.4
Discontinued Operations - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]      
Cash used in operating activities, discontinued operations $ 15.0 $ 15.0 $ 15.2
v3.25.4
Acquisitions - Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]      
Goodwill $ 1,949,702 $ 1,651,993 $ 1,588,331
Total Business Combinations      
Business Combination [Line Items]      
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent 17,163    
Business Combination, Recognized Asset Acquired, Inventory, Current 47,743    
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment 57,765    
Goodwill 217,129    
Intangible assets 176,402    
Business Combination, Recognized Liability Assumed, Deferred Tax Liability (50,667)    
Business Combination, Recognized Liability Assumed, Other Asset Liabilities (13,161)    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total 452,374    
EWM GmbH      
Business Combination [Line Items]      
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent 10,360    
Business Combination, Recognized Asset Acquired, Inventory, Current 40,081    
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment 51,481    
Goodwill 153,567    
Intangible assets 129,746    
Business Combination, Recognized Liability Assumed, Deferred Tax Liability (38,224)    
Business Combination, Recognized Liability Assumed, Other Asset Liabilities (12,271)    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total 334,740    
All Other Business Acquisitions      
Business Combination [Line Items]      
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent 6,803    
Business Combination, Recognized Asset Acquired, Inventory, Current 7,662    
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment 6,284    
Goodwill 63,562    
Intangible assets 46,656    
Business Combination, Recognized Liability Assumed, Deferred Tax Liability (12,443)    
Business Combination, Recognized Liability Assumed, Other Asset Liabilities (890)    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total 117,634    
Bavaria Schweisstechnik      
Business Combination [Line Items]      
Goodwill 39,000    
Aktiv Technologies Private Limited      
Business Combination [Line Items]      
Goodwill $ 16,000    
v3.25.4
Acquisitions - Preliminary Assets Acquired (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
EWM GmbH  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 129,746
All Other Business Acquisitions  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill 46,656
Customer relationships | EWM GmbH  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 89,095
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 20 years
Customer relationships | All Other Business Acquisitions  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 37,984
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 17 years
Customer relationships | Bavaria Schweisstechnik  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 23,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 18 years
Trade names | EWM GmbH  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 20,536
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 10 years
Trade names | All Other Business Acquisitions  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 6,484
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 10 years
Technology | EWM GmbH  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 20,115
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 10 years
Technology | All Other Business Acquisitions  
Business Combination [Line Items]  
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill $ 2,188
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 5 years
v3.25.4
Acquisitions (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2024
Jul. 02, 2024
Feb. 26, 2024
Jan. 11, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]              
Business Combination, Acquiree's Revenue since Acquisition Date, Actual         $ 79,000    
Business Combination, Acquisition-Related Cost, Expense         11,000    
Cash consideration, net of cash received         438,314 $ 153,664 $ 18,665
Goodwill         $ 1,949,702 $ 1,651,993 $ 1,588,331
SUMIG Soluções para Solda e Corte Ltda              
Business Combination [Line Items]              
Cash consideration, net of cash received $ 68,000            
Intangible assets 29,000            
Goodwill $ 39,000            
Linde Industries Private Limited              
Business Combination [Line Items]              
Intangible assets   $ 15,000          
Goodwill   46,000          
Purchase price   $ 69,000          
Sager S.A.              
Business Combination [Line Items]              
Purchase price     $ 18,000        
Therapy Equipment Limited              
Business Combination [Line Items]              
Cash consideration, net of cash received       $ 19,000      
v3.25.4
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Net sales $ 2,842,555 $ 2,740,803 $ 2,774,766
Equipment      
Disaggregation of Revenue [Line Items]      
Net sales 1,870,561 893,313 854,949
Consumables      
Disaggregation of Revenue [Line Items]      
Net sales $ 971,994 $ 1,847,490 $ 1,919,817
v3.25.4
Revenue - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]      
Contract liability $ 19.7 $ 26.4 $ 31.2
v3.25.4
Revenue - Allowance for Credit Loss Rollforward (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at Beginning of Period $ 23,850
Charged to Expense, net (173)
Write-Offs and Deductions (3,307)
Foreign Currency Translation 1,395
Balance at End of Period $ 21,765
v3.25.4
Earnings per Share from Continuing Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Computation of earnings per share from continuing operations – basic:      
Income from continuing operations attributable to ESAB Corporation $ 252,637 $ 287,151 $ 217,626
Distributed and undistributed earnings allocated to nonvested shares (1,218) (1,370) (1,555)
Income from continuing operations attributable to common stockholders $ 251,419 $ 285,781 $ 216,071
Weighted-average shares of common stock outstanding - basic (in shares) 60,680,448 60,427,743 60,233,623
Income per share from continuing operations – basic (in dollars per share) $ 4.14 $ 4.73 $ 3.59
Computation of earnings per share from continuing operations – diluted:      
Net effect of potentially dilutive securities (in shares) 585,846 674,320 422,123
Weighted-average shares of common stock outstanding - assuming dilution (in shares) 61,266,294 61,102,063 60,655,746
Income per share from continuing operations – assuming dilution (in dollars per share) $ 4.10 $ 4.68 $ 3.56
Net income $ 233,232 $ 270,748 $ 211,024
Noncontrolling Interest      
Computation of earnings per share from continuing operations – diluted:      
Net income $ 6,466 $ 5,906 $ 5,739
v3.25.4
Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income from continuing operations before income taxes:      
Domestic operations $ 36,517 $ 50,212 $ 37,364
Foreign operations 291,743 320,193 281,728
Income from continuing operations before income taxes 328,260 370,405 319,092
Current:      
Federal 7,566 8,983 12,548
State 1,929 2,635 3,760
Foreign 91,188 65,495 104,522
Current income tax 100,683 77,113 120,830
Deferred:      
Federal (4,381) 4,043 (11,897)
State (14) (126) (1,341)
Foreign (27,131) (3,682) (11,865)
Deferred Income Tax (31,526) 235 (25,103)
Income tax expense $ 69,157 $ 77,348 $ 95,727
v3.25.4
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Post-retirement benefit obligation $ 1,894 $ 1,229
Expenses currently not deductible 73,063 59,518
Net operating loss carryforward 90,458 86,716
Tax credit carryforward 8,323 5,137
Depreciation and amortization 6,544 4,286
Inventory 12,892 10,795
Capitalized R&D costs 22,035 20,556
Leases 27,831 21,490
Other assets 10,859 0
Valuation allowance (54,883) (65,007)
Deferred tax assets, net 199,016 144,720
Deferred tax liabilities:    
Depreciation and amortization (183,201) (125,227)
Leases (28,418) (22,084)
Outside basis differences and other (87,959) (87,434)
Total deferred tax liabilities (299,578) (234,745)
Total deferred tax liabilities, net $ (100,562) $ (90,025)
v3.25.4
Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Examination [Line Items]    
Other liabilities $ (182,898) $ (151,642)
Total deferred tax liabilities, net (100,562) (90,025)
Other Assets    
Income Tax Examination [Line Items]    
Other assets 58,217 44,816
Other Liabilities    
Income Tax Examination [Line Items]    
Other liabilities $ (158,779) $ (134,841)
v3.25.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Examination [Line Items]        
Effective Income Tax Rate Reconciliation, Percent 21.10%   30.00%  
Valuation allowance $ 54,883 $ 65,007    
Net operating loss carryforward, subject to expiration 2,200      
Unrecognized tax benefits 18,588 17,084 $ 30,871 $ 20,203
Unrecognized tax benefits, income tax penalties and interest accrued 5,300 4,700 12,100  
Unrecognized tax (benefits), income tax penalties and interest expense 200 $ 6,200 $ 7,900  
Foreign Tax Authority        
Income Tax Examination [Line Items]        
Operating loss carryforwards $ 357,000      
v3.25.4
Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning Balance $ 17,084 $ 30,871 $ 20,203
Addition for tax positions taken in prior periods 7,300 6,436 13,514
Reductions for tax positions taken in prior periods (2,201) (7,825)  
Reductions related to settlements with taxing authorities (3,624) (9,255) (4,160)
Reductions resulting from a lapse of applicable statute of limitations (1,484)    
Reductions resulting from a lapse of applicable statute of limitations   (51)  
Other, including the impact of foreign currency translation   (3,092)  
Other, including the impact of foreign currency translation 1,513   1,314
Ending Balance $ 18,588 $ 17,084 $ 30,871
v3.25.4
Income Taxes - Income Taxes Paid, Net of Refunds (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Federal $ 872    
State 1,439    
Foreign 90,379    
Income tax payments, net 92,690 $ 94,525 $ 132,902
India      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 11,833    
Brazil      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 11,537    
Switzerland      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 8,724    
China      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 8,572    
United Kingdom      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 6,765    
Peru      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 6,003    
Czech Republic      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign 5,798    
Mexico      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Foreign $ 5,039    
v3.25.4
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Taxes calculated at the United States federal statutory rate $ 68,950 $ 77,785 $ 67,010
United States federal statutory tax 21.00%    
State taxes $ 1,510 1,956 1,630
State and local income tax, net of federal income tax effect(1) 0.50%    
Valuation Allowance   (761) (12,308)
Other   2,269 4,329
Effect of tax rates on international operations   1,823 $ 1,548
Global Intangible Low-Taxed Income inclusion $ 24,828    
Global Intangible Low-Taxed Income inclusion 7.60%    
Subpart F income inclusion $ 9,663    
Subpart F income inclusion 2.90%    
Foreign-Derived Intangible Income deduction $ (5,563)    
Foreign-Derived Intangible Income deduction (1.70%)    
Foreign tax credit $ (33,516)    
Foreign tax credit (10.20%)    
Other $ (93)    
Other 0.00%    
Tax credits $ (916)    
Tax credits (0.30%)    
Nondeductible officer compensation $ 4,762    
Nondeductible officer compensation 1.50%    
Other $ (1,250)    
Other (0.40%)    
Changes in unrecognized tax benefits $ (2,897)    
Changes in unrecognized tax benefits (0.90%)    
Other adjustments $ (646)    
Other adjustments (0.20%)    
Effective Income Tax Rate Reconciliation, Percent 21.10%   30.00%
Changes in tax reserves   (4,206) $ 10,753
Research and development tax credits   (980) (714)
Effect of United States taxation on international operations   5,239 1,527
Permanent differences, net   (4,061) 10,077
Provision to return   (8,350) 703
Withholding taxes   6,634 11,172
Income tax expense $ 69,157 $ 77,348 $ 95,727
United Kingdom      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Valuation Allowance $ (11,965)    
Valuation allowance (3.70%)    
Other $ 1,147    
Other 0.40%    
Switzerland      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Other $ (2,286)    
Other (0.70%)    
Effect of tax rates on international operations $ (5,913)    
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent (1.80%)    
Peru      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Effect of tax rates on international operations $ 5,248    
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent 1.60%    
Foreign Tax Jurisdiction, Other      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Effect of tax rates on international operations $ 19,651    
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent 6.00%    
Czech Republic      
Income Tax Paid, by Individual Jurisdiction [Line Items]      
Valuation Allowance $ (1,555)    
Valuation allowance (0.50%)    
v3.25.4
Goodwill and Intangible Assets - Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Goodwill [Roll Forward]    
Balance beginning of period $ 1,651,993 $ 1,588,331
Goodwill attributable to acquisition(1) 219,628 91,196
Impact of foreign currency translation 78,081 (27,534)
Balance end of period 1,949,702 1,651,993
Americas Business Segment [Member]    
Goodwill [Roll Forward]    
Balance beginning of period 629,705 589,875
Goodwill attributable to acquisition(1) 2,500 44,505
Impact of foreign currency translation 14,812 (4,675)
Balance end of period 647,017 629,705
EMEA & APAC    
Goodwill [Roll Forward]    
Balance beginning of period 1,022,288 998,456
Goodwill attributable to acquisition(1) 217,128 46,691
Impact of foreign currency translation 63,269 (22,859)
Balance end of period $ 1,302,685 $ 1,022,288
v3.25.4
Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Intangible Assets Schedule [Line Items]    
Accumulated Amortization $ (467,904) $ (401,481)
Total intangible assets 1,140,910 889,474
Trade names    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 58,553 28,878
Accumulated Amortization (16,428) (11,832)
Customer relationships    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 661,002 506,226
Accumulated Amortization (288,727) (248,920)
Technology    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 101,214 71,912
Accumulated Amortization (64,631) (55,539)
Software    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 91,802 78,122
Accumulated Amortization (73,731) (62,391)
Other intangible assets    
Intangible Assets Schedule [Line Items]    
Gross Carrying Amount 31,219 30,424
Accumulated Amortization (24,387) (22,799)
Trade names    
Intangible Assets Schedule [Line Items]    
Indefinite-Lived Intangible Assets: $ 197,120 $ 173,912
v3.25.4
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense $ 43.3 $ 36.0 $ 39.7
v3.25.4
Goodwill and Intangible Assets - Expected Amortization Expense (Details )
$ in Thousands
Dec. 31, 2025
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Finite-Lived Intangible Asset, Expected Amortization, Year One $ 43,037
Finite-Lived Intangible Asset, Expected Amortization, Year Two 38,989
Finite-Lived Intangible Asset, Expected Amortization, Year Three 36,106
Finite-Lived Intangible Asset, Expected Amortization, Year Four 34,794
2030 $ 32,888
v3.25.4
Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 744,007 $ 599,606
Accumulated depreciation (362,131) (301,259)
Property, plant and equipment, net 381,876 298,347
Land    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 23,481 14,484
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 233,850 176,077
Buildings and improvements | Minimum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 5 years  
Buildings and improvements | Maximum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 40 years  
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 486,676 $ 409,045
Machinery and equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 3 years  
Machinery and equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Depreciable Life 15 years  
v3.25.4
Property, Plant and Equipment, Net - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment      
Property, Plant and Equipment [Line Items]      
Depreciation and other amortization $ 40.7 $ 30.6 $ 30.0
v3.25.4
Inventories, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials $ 173,458 $ 151,248
Work in process 40,033 41,698
Finished goods 307,517 251,994
Inventories, gross 521,008 444,940
Less: allowance for excess, slow-moving and obsolete inventory (39,243) (41,229)
Inventories, net $ 481,765 $ 403,711
v3.25.4
Leases (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]      
Operating lease expense $ 28,700 $ 24,900 $ 25,400
Non Cash Transaction, Right Of Use Lease Asset And Lease Liability 29,000    
Future lease payments by year:      
46387 28,379    
2027 26,093    
2028 19,582    
2029 14,418    
2030 12,754    
Thereafter 50,245    
Lessee, Operating Lease, Liability, to be Paid, Total 151,471    
Less: present value discount (41,249)    
Present value of lease liabilities $ 110,222    
Lessee, Operating Lease, Remaining Lease Term 7 years 1 month 6 days    
Operating leases 8.50%    
v3.25.4
Accrued and Other Liabilities - Current and Noncurrent (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
CURRENT LIABILITIES:    
Accrued taxes and deferred tax liabilities $ 53,728 $ 46,395
Compensation and related benefits 68,535 80,451
Asbestos liability 42,242 40,779
Contract liability 19,663 26,390
Lease liability 22,081 21,459
Warranty liability 12,573 12,794
Third-party commissions 19,371 17,346
Restructuring liability 17,297 4,732
Other 37,926 40,135
Accrued liabilities $ 301,986 $ 298,558
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Liabilities, Noncurrent [Abstract]    
Accrued taxes and deferred tax liabilities $ 182,898 $ 151,642
Compensation and related benefits 52,706 48,350
Asbestos liability 269,829 253,287
Contract liability $ 0 $ 0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Total accrued and other liabilities, Noncurrent Total accrued and other liabilities, Noncurrent
Lease liability $ 88,141 $ 66,042
Warranty liability 0 0
Third-party commissions 0 0
Restructuring liability 319 374
Other 63,343 13,241
Total accrued and other liabilities, Noncurrent 657,236 532,936
Interest Payable, Current 8,570 8,077
Interest Payable, Noncurrent $ 0 $ 0
v3.25.4
Accrued and Other Liabilities - Warranty Liability Rollforward (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Apr. 04, 2025
Dec. 31, 2025
Dec. 31, 2024
Movement in Standard Product Warranty Accrual [Roll Forward]      
Warranty liability, beginning of period $ 12,794 $ 12,794 $ 12,606
Accrued warranty expense 8,926   10,570
Changes in estimates related to pre-existing warranties 762   1,624
Cost of warranty service work performed $ (12,146)   (11,426)
Foreign exchange translation effect and other   2,237 (580)
Warranty liability, end of period   $ 12,573 $ 12,794
v3.25.4
Accrued and Other Liabilities - Restructuring Rollforward (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve [Roll Forward]      
Restructuring Charges, Total $ 27,756 $ 10,227 $ 24,110
Americas Business Segment [Member]      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 5,106 5,699  
Charges 27,756 10,227  
Payments (14,923) (10,400)  
Foreign Currency Translation and Other (323) (420)  
Balance at End of Period 17,616 5,106 5,699
Termination Benefits | Americas Business Segment [Member]      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 3,845 4,595  
Charges 19,174 4,538  
Payments (8,678) (5,288)  
Foreign Currency Translation and Other 709 0  
Balance at End of Period 15,050 3,845 4,595
Facility Closure Costs | Americas Business Segment [Member]      
Restructuring Reserve [Roll Forward]      
Balance at Beginning of Period 1,261 1,104  
Charges 8,582 5,689  
Payments (6,245) (5,112)  
Foreign Currency Translation and Other (1,032) (420)  
Balance at End of Period $ 2,566 $ 1,261 $ 1,104
v3.25.4
Benefit Plans - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Pension settlement gain $ 0 $ (12,155) $ 0
Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation 56,300 49,300  
Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets 8,800 6,300  
Plans with projected benefit obligations in excess of plan assets, projected benefit obligation 62,300 52,400  
Plans with projected benefit obligations in excess of plan assets, fair value of plan assets 11,800 7,200  
Expected employer contributions in the next fiscal year 5,200    
Defined contribution plan, cost 7,700 7,500 7,600
Foreign Plan      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 162,329 161,906  
All Pension Benefits      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 162,329 161,906 211,472
Change in benefit obligation: 196,619 189,874 242,743
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss 51,302 49,795  
Pension settlement gain 0 (12,155) 0
All Pension Benefits | Foreign Plan      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 27,377 21,894 65,278
Change in benefit obligation: $ 74,624 63,898 99,215
Pension settlement gain   $ (12,155) $ 0
v3.25.4
Benefit Plans - Obligation and Asset Rollforward (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Change in plan assets:      
Pension settlement gain $ 0 $ (12,155) $ 0
Foreign Plan      
Change in plan assets:      
Fair value of plan assets, beginning of year 161,906    
Fair value of plan assets, end of year 162,329 161,906  
All Pension Benefits      
Change in benefit obligation:      
Projected benefit obligation, beginning of year 189,874 242,743  
Service cost 1,466 1,429 1,439
Interest cost 8,475 8,828 11,170
Plan amendments 1,671 (9)  
Actuarial loss (gain) 1,109 (5,945)  
Foreign exchange effect 8,112 (5,386)  
Benefits paid (17,533) (21,242)  
Settlements (1,314) (31,583)  
Other 4,759 1,039  
Projected benefit obligation, end of year 196,619 189,874 242,743
Accumulated benefit obligation, end of year 192,972 186,689  
Change in plan assets:      
Fair value of plan assets, beginning of year 161,906 211,472  
Actual return on plan assets 8,657 12,389  
Employer contributions 4,874    
Employer contributions   4,309  
Foreign exchange effect 1,930 (2,028)  
Benefits paid (17,533) (21,242)  
Settlements (1,314) (43,283)  
Other 3,809 289  
Fair value of plan assets, end of year 162,329 161,906 211,472
Funded status, end of year (34,290) (27,968)  
Non-current assets 16,194 17,228  
Current liabilities (4,039) (3,113)  
Non-current liabilities (46,445) (42,083)  
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position, Total (34,290) (27,968)  
Pension settlement gain 0 (12,155) 0
All Pension Benefits | Foreign Plan      
Change in benefit obligation:      
Projected benefit obligation, beginning of year 63,898 99,215  
Service cost 1,466 1,429 1,439
Interest cost 2,513 2,576 4,148
Plan amendments 1,671 (9)  
Actuarial loss (gain) (1,721) 1,178  
Foreign exchange effect 8,112 (5,386)  
Benefits paid (4,760) (4,561)  
Settlements (1,314) (31,583)  
Other 4,759 1,039  
Projected benefit obligation, end of year 74,624 63,898 99,215
Accumulated benefit obligation, end of year 70,977 60,713  
Change in plan assets:      
Fair value of plan assets, beginning of year 21,894 65,278  
Actual return on plan assets 1,068 2,024  
Employer contributions 4,750    
Employer contributions   4,175  
Foreign exchange effect 1,930 (2,028)  
Benefits paid (4,760) (4,561)  
Settlements (1,314) (43,283)  
Other 3,809 289  
Fair value of plan assets, end of year 27,377 21,894 65,278
Funded status, end of year (47,247) (42,004)  
Non-current assets 2,164 2,072  
Current liabilities (3,914) (2,979)  
Non-current liabilities (45,497) (41,097)  
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position, Total $ (47,247) (42,004)  
Pension settlement gain   $ (12,155) $ 0
v3.25.4
Benefit Plans - Expected Benefit Payments (Details) - All Pension Benefits
$ in Thousands
Dec. 31, 2025
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2026 $ 20,672
2027 19,078
2028 18,208
2029 17,878
2030 17,812
2031 – 2035 77,553
Foreign Plan  
Defined Benefit Plan Disclosure [Line Items]  
2026 7,685
2027 6,525
2028 6,063
2029 6,229
2030 6,666
2031 – 2035 $ 29,705
v3.25.4
Benefit Plans - Plan Asset Allocation (Details)
Dec. 31, 2025
Dec. 31, 2024
Equity securities | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 0.00% 4.00%
United States | Czech Republic    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 0.00% 37.00%
International | Czech Republic    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 0.00% 13.00%
Fixed income | Czech Republic    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 90.00% 50.00%
Fixed income | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 14.00% 15.00%
Cash and cash equivalents | Czech Republic    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 10.00% 0.00%
Cash and cash equivalents | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 1.00% 1.00%
Insurance contracts | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 51.00% 44.00%
Investment funds | Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Actual asset allocation 34.00% 36.00%
v3.25.4
Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Czech Republic | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets $ 13,097 $ 379
Czech Republic | United States large cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 28,803
Czech Republic | United States small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 22,937
Czech Republic | International    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 17,566
Czech Republic | United States government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 121,856 69,152
Czech Republic | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 1,175
Czech Republic | Measured at Net Asset Value | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Measured at Net Asset Value | United States large cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 28,803
Czech Republic | Measured at Net Asset Value | United States small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 9,456
Czech Republic | Measured at Net Asset Value | International    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 17,566
Czech Republic | Measured at Net Asset Value | United States government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 121,856 69,152
Czech Republic | Measured at Net Asset Value | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level One | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 13,097 379
Czech Republic | Level One | United States large cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level One | United States small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 13,481
Czech Republic | Level One | International    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level One | United States government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level One | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 1,175
Czech Republic | Level Two | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Two | United States large cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Two | United States small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Two | International    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Two | United States government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Two | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | United States large cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | United States small/mid cap    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | International    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | United States government and corporate    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Czech Republic | Level Three | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 162,329 161,906
Foreign Plan | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 237 238
Foreign Plan | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 95 904
Foreign Plan | Non-United States government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 3,679 3,198
Foreign Plan | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 14,040 9,608
Foreign Plan | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 9,298 7,919
Foreign Plan | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 27 27
Foreign Plan | Measured at Net Asset Value    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 121,856 124,977
Foreign Plan | Measured at Net Asset Value | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Measured at Net Asset Value | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Measured at Net Asset Value | Non-United States government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Measured at Net Asset Value | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Measured at Net Asset Value | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Measured at Net Asset Value | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level One    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 17,108 19,375
Foreign Plan | Level One | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 237 238
Foreign Plan | Level One | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 95 904
Foreign Plan | Level One | Non-United States government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 3,679 3,198
Foreign Plan | Level One | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level One | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level One | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Two    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 23,365 17,554
Foreign Plan | Level Two | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Two | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Two | Non-United States government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Two | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 14,040 9,608
Foreign Plan | Level Two | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 9,298 7,919
Foreign Plan | Level Two | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 27 27
Foreign Plan | Level Three    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Cash and cash equivalents    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Non-United States government and corporate bonds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Insurance contracts    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Investment funds    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets 0 0
Foreign Plan | Level Three | Other    
Defined Benefit Plan Disclosure [Line Items]    
Pension plan assets $ 0 $ 0
v3.25.4
Benefit Plans - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Components of Net Periodic Benefit Cost:      
Settlement loss(1) $ 0 $ 12,155 $ 0
All Pension Benefits      
Components of Net Periodic Benefit Cost:      
Service cost 1,466 1,429 1,439
Interest cost 8,475 8,828 11,170
Amortization 1,500 1,634 1,206
Settlement loss(1) 0 12,155 0
Other 122 (179) 0
Expected return on plan assets (7,917) (9,410) (11,391)
Net periodic benefit cost 3,646 14,457 2,424
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Current year net actuarial loss (gain) 1,501 (9,598) (7,021)
Current year prior service cost (income) 1,620 (9) 175
Less amounts included in net periodic benefit cost:      
Amortization of net loss (1,506) (1,676) (1,575)
Settlement / divestiture / other loss (114) (455) (1,079)
Amortization of prior service cost (income) 6 42 38
Total recognized in Other comprehensive income (loss) 1,507 (11,696) (9,462)
Foreign Plan | All Pension Benefits      
Components of Net Periodic Benefit Cost:      
Service cost 1,466 1,429 1,439
Interest cost 2,513 2,576 4,148
Amortization 155 130 40
Settlement loss(1)   12,155 0
Other 122 (179) (331)
Expected return on plan assets (881) (1,038) (2,475)
Net periodic benefit cost 3,375 15,073 2,821
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Current year net actuarial loss (gain) (777) (483) 1,984
Current year prior service cost (income) 1,620 (9) 175
Less amounts included in net periodic benefit cost:      
Amortization of net loss (161) (172) (78)
Settlement / divestiture / other loss (114) (454) (1,079)
Amortization of prior service cost (income) 6 42 38
Total recognized in Other comprehensive income (loss) $ 574 $ (1,076) $ 1,040
v3.25.4
Benefit Plans - Accumulated Other Comprehensive Income (Details) - All Pension Benefits - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]    
Net actuarial loss $ 49,797 $ 49,917
Prior service cost (income) 1,505 (122)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax, Total $ 51,302 $ 49,795
v3.25.4
Benefit Plans - Key Economic Assumptions (Details) - All Pension Benefits
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 4.70% 4.80%  
Weighted-average discount rate, net periodic benefit cost 4.80% 4.40% 4.60%
Weighted-average expected return on plan assets, net periodic benefit cost 4.80% 5.10% 5.00%
Foreign Plan      
Defined Benefit Plan Disclosure [Line Items]      
Weighted-average discount rate, benefit obligation 4.30% 3.70%  
Weighted-average rate of increase in compensation levels for active foreign plans 3.50% 3.10%  
Weighted-average discount rate, net periodic benefit cost 3.70% 3.90% 4.30%
Weighted-average expected return on plan assets, net periodic benefit cost 4.10% 4.40% 4.10%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost 3.10% 3.10% 3.20%
v3.25.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Total debt $ 1,243,215  
Current portion of long-term debt (2,412) $ (15,000)
Unamortized deferred financing fees (12,500)  
Other Assets    
Debt Instrument [Line Items]    
Unamortized deferred financing fees (4,200)  
Long-term Debt    
Debt Instrument [Line Items]    
Total debt 1,243,215 1,085,000
Current portion of long-term debt (2,412) (15,000)
Unamortized deferred financing fees (8,263) (9,261)
Long-term debt 1,232,540 1,060,739
Senior Note Offering | Senior Notes    
Debt Instrument [Line Items]    
Total debt 700,000 700,000
Term loan | The Credit Agreement | Line of Credit    
Debt Instrument [Line Items]    
Total debt 350,000 385,000
Term loan | The Credit Agreement | Senior Notes    
Debt Instrument [Line Items]    
Total debt 700,000  
Revolving credit facility | The Credit Agreement | Line of Credit    
Debt Instrument [Line Items]    
Total debt $ 185,000 $ 0
v3.25.4
Debt - Narrative (Details) - USD ($)
Oct. 16, 2025
Apr. 04, 2022
Dec. 31, 2025
Dec. 31, 2024
Apr. 09, 2024
Debt Instrument [Line Items]          
Letters of credit outstanding amount     $ 33,700,000    
Unamortized deferred financing fees     12,500,000    
Total debt     1,243,215,000    
Other Assets          
Debt Instrument [Line Items]          
Unamortized deferred financing fees     4,200,000    
Long-term Debt          
Debt Instrument [Line Items]          
Unamortized deferred financing fees     8,263,000 $ 9,261,000  
Total debt     $ 1,243,215,000 1,085,000,000  
The Credit Agreement          
Debt Instrument [Line Items]          
Weighted-average interest rate (as a percent)     5.40%    
The Credit Agreement | Minimum | SOFR          
Debt Instrument [Line Items]          
Basis spread on variable rate (as a percent)   1.125%      
The Credit Agreement | Minimum | Base Rate          
Debt Instrument [Line Items]          
Basis spread on variable rate (as a percent)   0.125%      
The Credit Agreement | Maximum | SOFR          
Debt Instrument [Line Items]          
Basis spread on variable rate (as a percent)   1.75%      
The Credit Agreement | Maximum | Base Rate          
Debt Instrument [Line Items]          
Basis spread on variable rate (as a percent)   0.75%      
Senior Note Offering | Senior Notes          
Debt Instrument [Line Items]          
Principal amount         $ 700,000,000
Stated interest rate         6.25%
Total debt     $ 700,000,000 700,000,000  
Revolving credit facility | Line of Credit          
Debt Instrument [Line Items]          
Principal amount $ 1,050,000,000.00        
Cash consideration 185,000,000        
Revolving credit facility | The Credit Agreement | Line of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity   $ 750,000,000      
Line of credit facility, remaining borrowing capacity     865,000,000    
Total debt     185,000,000 0  
Revolving credit facility | Foreign Currency Sublimit | Line of Credit          
Debt Instrument [Line Items]          
Principal amount 300,000,000        
Revolving credit facility | Swing Line Loan Sub Facility | Line of Credit          
Debt Instrument [Line Items]          
Principal amount 50,000,000        
Term loan | Line of Credit          
Debt Instrument [Line Items]          
Principal amount $ 350,000,000        
Term loan | The Credit Agreement | Senior Notes          
Debt Instrument [Line Items]          
Principal amount   $ 600,000,000      
Debt term (in days)   364 days      
Term loan | The Credit Agreement | Line of Credit          
Debt Instrument [Line Items]          
Principal amount   $ 400,000,000      
Total debt     350,000,000 $ 385,000,000  
Term loan | The Credit Agreement | Senior Notes          
Debt Instrument [Line Items]          
Total debt     700,000,000    
Letter of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity     113,300,000    
Letter of Credit | Uncommitted Credit Line          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity     $ 50,000,000    
v3.25.4
Debt - Schedule of Debt Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
46387 $ 2,412  
2027 10,408  
2028 10,408  
2029 719,158  
2030 500,829  
Long-term debt 1,243,215  
Unamortized deferred financing fees 12,500  
Long-term Debt    
Debt Instrument [Line Items]    
Long-term debt 1,243,215 $ 1,085,000
Unamortized deferred financing fees $ 8,263 $ 9,261
v3.25.4
Derivatives - Narratives (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2025
EUR (€)
Dec. 31, 2024
USD ($)
Aug. 22, 2024
USD ($)
agreement
Aug. 22, 2024
EUR (€)
agreement
Jun. 25, 2024
agreement
Jul. 22, 2022
agreement
Jul. 14, 2022
USD ($)
agreement
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Increase derivative assets and liabilities $ 0.1              
Designated as Hedging Instrument | Cash Flow Hedging                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Notional amount       $ 100.0 € 90      
Interest rate swap agreement                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Number of derivative instruments held | agreement               2
Notional amount 300.0             $ 600.0
Fixed interest rate               3.293%
Interest rate swap agreement | Cash Flow Hedging                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Proceeds From Derivative Instrument, Operating Activities 5.5              
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax 5.5              
Interest rate swap agreement | Minimum                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Basis spread on variable rate (as a percent)               1.125%
Interest rate swap agreement | Maximum                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Basis spread on variable rate (as a percent)               1.75%
Cross-currency swap agreements                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Number of derivative instruments held | agreement       2 2 4 2  
Cross-currency swap agreements | Designated as Hedging Instrument                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Notional amount 275.0 € 270            
Cross-currency swap agreements | Not Designated as Hedging Instrument                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Notional amount $ 105.2   $ 178.7          
v3.25.4
Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Liabilities $ 48,778 $ 1,830
Other Assets 0 842
Cross-currency swap agreements    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Liabilities 48,778 1,830
Other Assets 0 0
Interest rate swap agreement    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Liabilities 0 0
Other Assets $ 0 $ 842
v3.25.4
Derivatives - Derivatives Not Designated as Hedging Instruments (Details) - Foreign currency contracts - Not Designated as Hedging Instrument - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Derivative [Line Items]    
Derivative liability, current $ 183 $ 379
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Derivative asset, current $ 780 $ 255
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
v3.25.4
Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets:    
Cash equivalents $ 11,965 $ 8,990
Deferred Compensation Plan Assets 7,214 5,242
Total assets at fair value 20,036 15,731
Liabilities:    
Deferred compensation plans 7,214 5,242
Total liabilities at fair value 56,252 7,853
Cross-currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 857 657
Liabilities:    
Derivative liabilities 260 781
Cross-currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 48,778 1,830
Interest rate swap agreement    
Assets:    
Derivative Asset 0 842
Level One    
Assets:    
Cash equivalents 11,965 8,990
Deferred Compensation Plan Assets 0 0
Total assets at fair value 11,965 8,990
Liabilities:    
Deferred compensation plans 0 0
Total liabilities at fair value 0 0
Level One | Cross-currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 0 0
Liabilities:    
Derivative liabilities 0 0
Level One | Cross-currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 0 0
Level One | Interest rate swap agreement    
Assets:    
Derivative Asset 0 0
Level Two    
Assets:    
Cash equivalents 0 0
Deferred Compensation Plan Assets 7,214 5,242
Total assets at fair value 8,071 6,741
Liabilities:    
Deferred compensation plans 7,214 5,242
Total liabilities at fair value 56,252 7,853
Level Two | Cross-currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 857 657
Liabilities:    
Derivative liabilities 260 781
Level Two | Cross-currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 48,778 1,830
Level Two | Interest rate swap agreement    
Assets:    
Derivative Asset 0 842
Level Three    
Assets:    
Cash equivalents 0 0
Deferred Compensation Plan Assets 0 0
Total assets at fair value 0 0
Liabilities:    
Deferred compensation plans 0 0
Total liabilities at fair value 0 0
Level Three | Cross-currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative Asset 0 0
Liabilities:    
Derivative liabilities 0 0
Level Three | Cross-currency swap agreements | Designated as Hedging Instrument    
Liabilities:    
Derivative liabilities 0 0
Level Three | Interest rate swap agreement    
Assets:    
Derivative Asset $ 0 $ 0
v3.25.4
Equity - Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance $ 1,808,249 $ 1,647,657 $ 1,388,458
Other comprehensive income (loss) before reclassifications:      
Foreign currency translation adjustment 190,923 (108,472) 47,258
Ending balance 2,211,529 1,808,249 1,647,657
Accumulated Other Comprehensive Loss      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (729,574) (624,272) (674,988)
Other comprehensive income (loss) before reclassifications:      
Net actuarial loss (1,811) 9,069 8,969
Foreign currency translation adjustment 186,652 (121,101) (23,307)
Gain on long-term intra-entity foreign currency transactions 5,448 14,136 70,428
Unrealized gain on cash flow hedges 16 4,426 4,834
Other comprehensive income (loss) before reclassifications 190,305 (93,470) 60,924
Amounts reclassified from Accumulated other comprehensive loss (447) (10,126) (10,208)
Purchase related to noncontrolling interest   (1,706)  
Net current period Other comprehensive income (loss) 189,858 (105,302) 50,716
Ending balance (539,716) (729,574) (624,272)
Net Unrecognized Pension and Other Post-Retirement Benefit Cost      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (50,352) (59,805) (63,847)
Other comprehensive income (loss) before reclassifications:      
Net actuarial loss (1,811) 9,069 8,969
Foreign currency translation adjustment (899) 530 (3,285)
Gain on long-term intra-entity foreign currency transactions 0 0 0
Unrealized gain on cash flow hedges 0 0 0
Other comprehensive income (loss) before reclassifications (2,710) 9,599 5,684
Amounts reclassified from Accumulated other comprehensive loss 1,385 (146) (1,642)
Purchase related to noncontrolling interest   0  
Net current period Other comprehensive income (loss) (1,325) 9,453 4,042
Ending balance (51,677) (50,352) (59,805)
Foreign Currency Translation Adjustment      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (679,791) (554,622) (613,907)
Other comprehensive income (loss) before reclassifications:      
Net actuarial loss 0 0 0
Foreign currency translation adjustment 224,018 (137,599) (11,143)
Gain on long-term intra-entity foreign currency transactions 5,448 14,136 70,428
Unrealized gain on cash flow hedges 0 0 0
Other comprehensive income (loss) before reclassifications 229,466 (123,463) 59,285
Amounts reclassified from Accumulated other comprehensive loss 0 0 0
Purchase related to noncontrolling interest   (1,706)  
Net current period Other comprehensive income (loss) 229,466 (125,169) 59,285
Ending balance (450,325) (679,791) (554,622)
Net Investment Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance (1,247) (17,215) (8,336)
Other comprehensive income (loss) before reclassifications:      
Net actuarial loss 0 0 0
Foreign currency translation adjustment (36,467) 15,968 (8,879)
Gain on long-term intra-entity foreign currency transactions 0 0 0
Unrealized gain on cash flow hedges 0 0 0
Other comprehensive income (loss) before reclassifications (36,467) 15,968 (8,879)
Amounts reclassified from Accumulated other comprehensive loss 0 0 0
Purchase related to noncontrolling interest   0  
Net current period Other comprehensive income (loss) (36,467) 15,968 (8,879)
Ending balance (37,714) (1,247) (17,215)
Cash Flow Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Beginning balance 1,816 7,370 11,102
Other comprehensive income (loss) before reclassifications:      
Net actuarial loss 0 0 0
Foreign currency translation adjustment 0 0 0
Gain on long-term intra-entity foreign currency transactions 0 0 0
Unrealized gain on cash flow hedges 16 4,426 4,834
Other comprehensive income (loss) before reclassifications 16 4,426 4,834
Amounts reclassified from Accumulated other comprehensive loss (1,832) (9,980) (8,566)
Purchase related to noncontrolling interest   0  
Net current period Other comprehensive income (loss) (1,816) (5,554) (3,732)
Ending balance $ 0 $ 1,816 $ 7,370
v3.25.4
Equity - Narratives (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Aug. 13, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share Repurchase Program, Authorized, Number of Shares     5
Common stock, par value (in dollars per share) $ 0.001 $ 0.001  
Stock repurchase program, authorized amount $ 0    
Unrecognized stock-based compensation expense related to stock options 2,900    
Fair value of vested shares 15,500    
Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expenses $ 3,000    
Unrecognized compensation cost, period for recognition (in years) 1 year 9 months 18 days    
Performance Shares And Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation cost, period for recognition (in years) 2 years 4 months 24 days    
Unrecognized stock-based compensation expense $ 24,700    
PRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expenses $ 2,700    
Award performance period 3 years    
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Performance vesting period (in years) 3 years    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expenses $ 11,200    
Maximum | Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum term (in years) 10 years    
v3.25.4
Equity - PRSU and RSU Activity (Details)
12 Months Ended
Dec. 31, 2025
$ / shares
shares
PRSUs  
Number of Units  
Number of units, nonvested, beginning balance (in shares) | shares 200,642
Granted (in shares) | shares 100,947
Vested (in shares) | shares 93,799
Forfeited and expired (in shares) | shares 20,231
Number of units, nonvested, ending balance (in shares) | shares 187,559
Weighted- Average Grant-Date Fair Value  
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 68.44
Awards converted from Former Parent plan (in usd per share) | $ / shares 131.81
Granted (in usd per share) | $ / shares 49.43
Vested (in usd per share) | $ / shares 90.83
Forfeited and expired (in usd per share) | $ / shares $ 97.48
RSUs  
Number of Units  
Number of units, nonvested, beginning balance (in shares) | shares 373,620
Granted (in shares) | shares 129,729
Vested (in shares) | shares 173,517
Forfeited and expired (in shares) | shares 31,235
Number of units, nonvested, ending balance (in shares) | shares 298,597
Weighted- Average Grant-Date Fair Value  
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares $ 67.02
Awards converted from Former Parent plan (in usd per share) | $ / shares 123.38
Granted (in usd per share) | $ / shares 62.38
Vested (in usd per share) | $ / shares 87.65
Forfeited and expired (in usd per share) | $ / shares $ 92.20
v3.25.4
Commitments and Contingencies - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Future claims period (in years) 15 years
Unconditional purchase obligation $ 162.4
v3.25.4
Commitments and Contingencies - Claims Rollforward (Details)
12 Months Ended
Dec. 31, 2025
USD ($)
claim
Dec. 31, 2024
USD ($)
claim
Loss Contingency Accrual [Roll Forward]    
Claims unresolved, beginning of period 13,758 13,648
Claims filed 5,279 5,005
Claims resolved (4,201) (4,895)
Claims unresolved, end of period 14,836 13,758
Average cost of resolved claims | $ $ 12,018 $ 10,574
v3.25.4
Commitments and Contingencies - Asbestos Litigation (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]    
Long-term asbestos insurance asset $ 235,361 $ 234,951
Long-term asbestos insurance receivable 16,811 16,961
Accrued asbestos liability 42,242 40,779
Asbestos liability $ 269,829 $ 253,287
v3.25.4
Segment Information - Narratives (Details)
12 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.4
Segment Information - Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Net sales $ 2,842,555 $ 2,740,803 $ 2,774,766
Cost of sales 1,794,213 1,703,348 1,759,015
Gross profit 1,048,342 1,037,455 1,015,751
Allocated operating expense: 144,781 162,324 168,652
Other operating expense: 343,851 346,357 345,997
Adjusted EBITDA 559,710 528,774 501,102
Depreciation, amortization and other impairment charges: 84,105 66,790 75,034
Capital expenditures: 47,287 51,779 48,178
Net income from continuing operations 259,103 293,057 223,365
Income tax expense 69,157 77,348 95,727
Interest expense and other, net 83,910 64,890  
Interest income and other, net     85,074
Pension settlement loss 0 12,155 0
Restructuring and other related charges 27,756 10,227 24,110
Acquisition - amortization and other related charges 72,063 34,479 36,851
Depreciation and other amortization 47,721 36,618 35,975
Investments in equity method investees: 29,558 28,885  
Total assets: 4,766,094 4,033,975  
Business Combination, Transaction, Diligence, And Integration Related Costs 31,500 4,200 2,600
Amortization Of Intangibles And Inventory Fair Value Charges 40,500 30,300 34,200
Czech Republic      
Segment Reporting Information [Line Items]      
Net sales 579,300 595,600 619,100
Americas Segment [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,130,338 1,176,745 1,214,998
Cost of sales 693,108 711,082 760,134
Allocated operating expense: 51,057 64,517 64,668
Other operating expense: 160,805 161,946 165,454
Adjusted EBITDA 225,368 239,200 224,742
Depreciation, amortization and other impairment charges: 34,050 30,813 34,589
Capital expenditures: 18,791 22,645 21,576
Investments in equity method investees: 0 0  
Total assets: 1,717,390 1,796,167  
EMEA and APAC Segment [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,712,217 1,564,058 1,559,768
Cost of sales 1,101,105 992,266 998,881
Allocated operating expense: 93,724 97,807 103,984
Other operating expense: 183,046 184,411 180,543
Adjusted EBITDA 334,342 289,574 276,360
Depreciation, amortization and other impairment charges: 50,055 35,977 40,445
Capital expenditures: 28,496 29,134 $ 26,602
Investments in equity method investees: 29,558 28,885  
Total assets: $ 3,048,704 $ 2,237,808  
v3.25.4
Segment Information - Net Sales and PPE by Geography (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Property, plant and equipment, net $ 381,876 $ 298,347
Czech Republic    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 75,028 55,554
United States    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 72,617 73,036
India    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 48,245 11,191
Mexico    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 31,437 31,506
Mexico    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net 23,464 20,495
Other foreign countries    
Segment Reporting Information [Line Items]    
Property, plant and equipment, net $ 131,085 $ 106,565
v3.25.4
Subsequent Events (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Jan. 16, 2026
Subsequent Event [Line Items]          
Revenue from Contract with Customer, Excluding Assessed Tax   $ 2,842,555 $ 2,740,803 $ 2,774,766  
Subsequent Event          
Subsequent Event [Line Items]          
Dividends payable         $ 6,100
Subsequent Event | Eddyfi Technologies          
Subsequent Event [Line Items]          
Purchase price $ 1,450,000        
Business Combination, Consideration Transferred, Liabilities Incurred $ 318,000        
v3.25.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Charged to Expense, net $ (173)    
Allowance for credit losses      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 23,850 $ 25,477 $ 23,471
Charged to Expense, net (173) 2,248 3,902
Write-Offs Write-Downs Deductions and Other (3,307) (2,423) (2,289)
Foreign Currency Translation 1,395 (1,452) 393
Balance at End of Period 21,765 23,850 25,477
Valuation allowance for deferred tax assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 65,007 79,355 88,202
Charged to Expense, net (13,285) (761) (12,283)
Write-Offs Write-Downs Deductions and Other 2,997 (12,478) 0
Foreign Currency Translation 164 (1,109) 3,426
Balance at End of Period $ 54,883 $ 65,007 $ 79,355